https://curecurrent.com/trials/efficacy-of-cadonilimab-in-non-squamous-non-small-cell-lung-cancer-patients-resistant-to-egfr-tki-47001https://curecurrent.com/trials/a-multicenter-retrospective-review-to-evaluate-the-feasibility-of-dye-marking-using-the-ion-endoluminal-system-47002https://curecurrent.com/trials/single-center-prospective-study-on-the-identification-and-delineation-of-brain-and-lung-tumors-and-at-risk-organs-and-fu-47003https://curecurrent.com/trials/multi-omics-testing-for-immunotherapy-efficacy-evaluation-motivation-47004https://curecurrent.com/trials/inod-ultrasound-guided-needle-biopsy-system-study-47005https://curecurrent.com/trials/treatment-of-lung-adenocarcinoma-with-bronchioloalveolar-feature-47006https://curecurrent.com/trials/a-prospective-cohort-study-to-evaluate-molecular-prognostic-factors-and-resistance-mechanisms-to-osimertinib-in-adjuvant-47007https://curecurrent.com/trials/a-randomised-open-label-phase-iii-trial-of-reduced-frequency-pembrolizumab-immunotherapy-for-first-line-treatment-of-pat-47008https://curecurrent.com/trials/found-ancillary-study-to-smile-protocol-nct03654105-47009https://curecurrent.com/trials/early-lung-cancer-detection-in-high-risk-individuals-47010https://curecurrent.com/trials/safety-and-tolerability-evaluation-of-low-dose-radiation-in-combination-with-cs1001-in-relapsed-sclc-patients-47011https://curecurrent.com/trials/plasma-microrna-profiling-as-first-line-screening-test-for-lung-cancer-detection-a-prospective-study-47012https://curecurrent.com/trials/adebrelimab-plus-chemotherapy-as-neoadjuvant-therapy-in-resectable-nsclc-harboring-driver-gene-mutations-47013https://curecurrent.com/trials/a-study-of-plm60-in-subjects-with-relapsed-small-cell-lung-cancer-after-platinum-based-first-line-chemotherapy-47014https://curecurrent.com/trials/the-role-of-narrow-band-imaging-nbi-bronchoscopy-in-detecting-bronchial-squamous-dysplasia-in-lung-cancer-47015https://curecurrent.com/trials/a-first-in-humans-dose-finding-study-for-an-aryl-hydrocarbon-receptor-inhibitor-ahri-in-patients-with-advanced-cancer-47016https://curecurrent.com/trials/efficacy-and-safety-of-tislelizumab-combined-with-bevacizumab-and-albumin-paclitaxel-in-lung-adenocarcinoma-47017https://curecurrent.com/trials/exploratory-drug-interaction-study-between-smis-and-doacs-47018https://curecurrent.com/trials/study-of-alkotinib-in-patients-with-advanced-non-small-cell-lung-cancer-47019https://curecurrent.com/trials/a-dose-escalation-and-cohort-expansion-study-of-subcutaneously-administered-cytokine-alks-4230-nemvaleukin-alfa-as-a-sin-47020https://curecurrent.com/trials/study-evaluating-efficacy-and-safety-of-capmatinib-in-combination-with-osimertinib-in-adult-subjects-with-non-small-cell-47021https://curecurrent.com/trials/covid-19-infection-and-multiple-myeloma-47022https://curecurrent.com/trials/implementation-of-lung-cancer-screening-in-the-first-line-zone-of-zora-flanders-using-a-low-dose-ct-scan-47023https://curecurrent.com/trials/bms-986012-in-relapsed-refractory-sclc-47024https://curecurrent.com/trials/t790m-plasma-testing-methodology-comparison-and-clinical-validation-47025https://curecurrent.com/trials/fr901228-in-treating-patients-with-refractory-or-progressive-small-cell-lung-cancer-or-non-small-cell-lung-cancer-47026https://curecurrent.com/trials/artemis-007-hs-20093-in-patients-with-extensive-stage-small-cell-lung-cancer-47027https://curecurrent.com/trials/vaccine-therapy-in-treating-patients-with-colon-pancreatic-or-lung-cancer-47028https://curecurrent.com/trials/safety-tolerability-and-anti-tumor-activity-of-afm24-in-combination-with-snk01-in-subjects-with-advanced-metastatic-egfr-47029https://curecurrent.com/trials/ha-wbrt-sib-for-brain-metastasis-of-lung-cancer-47030https://curecurrent.com/trials/dual-energy-ct-on-plan-quality-dose-delivery-accuracy-and-simulated-outcomes-of-patients-treated-with-proton-or-photon-t-47031https://curecurrent.com/trials/atezolizumab-in-advanced-non-small-cell-lung-cancer-with-rare-histologies-chance-trial-47032https://curecurrent.com/trials/the-predictive-biomarkers-in-patients-with-locally-advanced-non-small-cell-lung-cancer-47033https://curecurrent.com/trials/canine-assisted-profiling-of-lung-cancer-from-human-breath-47034https://curecurrent.com/trials/sabr-scan-trial-for-pulmonary-oligometastases-47035https://curecurrent.com/trials/study-evaluating-hemay020-in-subjects-with-advanced-solid-cancer-47036https://curecurrent.com/trials/nivolumab-and-ipilimumab-uv1-vaccination-as-second-line-treatment-in-patients-with-malignant-mesothelioma-47037https://curecurrent.com/trials/efficacy-and-safety-of-single-port-surgical-robot-system-in-thoraic-surgery-47038https://curecurrent.com/trials/durvalumab-medi4736-after-chemoradiotherapy-dart-for-nsclc-a-translational-and-biomarker-study-47039https://curecurrent.com/trials/radio-immuno-modulation-in-lung-cancer-47040https://curecurrent.com/trials/a-study-to-assess-bms-986207-in-combination-with-nivolumab-and-ipilimumab-as-first-line-treatment-for-participants-with-47041https://curecurrent.com/trials/effect-of-chemotherapy-with-paclitaxel-cisplatin-on-development-dysgeusia-in-non-small-cell-lung-cancer-47042https://curecurrent.com/trials/efficacy-and-safety-of-maintenance-apatinib-combined-with-pemetrexed-in-advanced-non-squamous-non-small-cell-lung-cancer-47043https://curecurrent.com/trials/optimizing-breathing-techniques-for-radiotherapy-of-esophageal-and-lung-carcinomas-47044https://curecurrent.com/trials/expanded-access-for-loxo-260-in-participants-with-cancer-caused-by-an-abnormal-ret-gene-that-did-not-respond-is-no-longe-47045https://curecurrent.com/trials/recombinant-human-endostatin-combined-with-envafolimab-and-synchronal-radiochemotherapy-47046https://curecurrent.com/trials/pembrolizumab-idelalisib-for-lung-cancer-study-47047https://curecurrent.com/trials/pemetrexed-plus-apatinib-maintenance-treatment-in-patients-with-non-squamous-non-small-cell-lung-cancer-patients-who-hav-47048https://curecurrent.com/trials/improving-function-welfare-of-late-stage-cancer-subjects-by-acc-47049https://curecurrent.com/trials/physical-therapy-in-patients-undergoing-allo-hsct-with-cgvhd-47050https://curecurrent.com/trials/ai-determine-malignancy-of-ggo-on-chest-ct-47051https://curecurrent.com/trials/neoadjuvant-therapy-with-iruplinalkib-for-potentially-resectable-alk-positive-nsclc-a-single-arm-exploratory-trial-47052https://curecurrent.com/trials/flt3-ligand-cd40-agonist-antibody-and-stereotactic-radiotherapy-47053https://curecurrent.com/trials/clinical-trial-assessing-the-efficacy-of-abscopal-effect-induced-by-sbrt-and-immunotherapy-in-advanced-nsclc-47054https://curecurrent.com/trials/mechanisms-of-resistance-in-egfr-mutated-nonpretreated-advanced-lung-cancer-receiving-osimertib-47055https://curecurrent.com/trials/feasibility-of-immunotherapy-plus-chemotherapy-administration-to-patients-with-bronchial-cancer-in-a-hospital-at-home-se-47056https://curecurrent.com/trials/effects-of-digital-therapeutic-in-whole-process-management-of-lung-cancer-47057https://curecurrent.com/trials/a-study-of-camrelizumab-combined-with-chemotherapy-thalidomide-in-first-line-treatment-of-patients-with-advanced-non-sma-47058https://curecurrent.com/trials/lung-ultrasound-score-after-ent-cancer-surgery-47059https://curecurrent.com/trials/using-ex-vivo-tumoroids-to-predict-immunotherapy-response-in-nsclc-47060https://curecurrent.com/trials/pilot-immunotherapy-study-with-letetresgene-autoleucel-lete-cel-gsk3377794-t-cells-in-new-york-esophageal-squamous-cell-47061https://curecurrent.com/trials/consistency-analysis-of-pd-l1s-in-advanced-nsclc-tissues-and-in-plasma-exosomes-before-and-after-radiotherapy-47062https://curecurrent.com/trials/exploration-on-the-value-of-mrd-based-on-ctdna-detection-in-predicting-recurrence-of-resected-non-small-cell-lung-cancer-47063https://curecurrent.com/trials/oral-microbiome-diagnostics-of-lung-cancer-47064https://curecurrent.com/trials/real-world-treatment-patterns-and-associated-outcomes-in-patients-with-resectable-early-stage-non-small-cell-lung-cancer-47065https://curecurrent.com/trials/imfinzi-specific-clinical-experience-investigation-in-patients-with-nsclc-after-definitive-chemoradiation-therapy-47066https://curecurrent.com/trials/trial-of-dose-escalated-bgb324-in-previously-treated-non-small-cell-lung-cancer-47067https://curecurrent.com/trials/study-of-cadonilimab-combined-with-bevacizumab-and-standard-chemotherapy-as-first-line-therapy-in-unresectable-pleural-m-47068https://curecurrent.com/trials/ak104-with-chemotherapy-as-neoadjuvant-and-adjuvant-therapy-for-resectable-non-small-cell-lung-cancer-47069https://curecurrent.com/trials/durvalumab-as-maintenance-in-patients-who-received-chemoradiotherapy-for-unresectable-stage-iii-nsclc-real-world-data-fr-47070https://curecurrent.com/trials/feasibility-of-an-acute-physical-exercise-before-treatment-infusion-for-metastatic-lung-cancer-patients-47071https://curecurrent.com/trials/a-multicenter-real-world-study-of-adebrelimab-in-the-treatment-of-extensive-stage-small-cell-lung-cancer-47072https://curecurrent.com/trials/window-of-opportunity-study-of-vs-6063-defactinib-in-surgical-resectable-malignant-pleural-mesothelioma-participants-47073https://curecurrent.com/trials/detection-of-minimal-residual-disease-in-resectable-stage-ii-iiib-non-small-cell-lung-cancer-47074https://curecurrent.com/trials/cryoablation-combined-with-cardonilizumab-and-bevacizumab-in-hepatocellular-carcinoma-with-pulmonary-metastases-47075https://curecurrent.com/trials/prospective-epidemiological-study-of-metastatic-non-small-cell-lung-cancer-nsclc-in-latin-america-47076https://curecurrent.com/trials/retrospective-epidemiological-study-of-locally-advanced-non-small-cell-lung-cancer-patients-in-brazil-47077https://curecurrent.com/trials/novel-light-delivery-method-for-performing-transbronchial-photodynamic-therapy-for-peripheral-lung-cancer-47078https://curecurrent.com/trials/characteristics-treatment-patterns-and-outcomes-for-patients-with-surgically-resected-lung-cancers-47079https://curecurrent.com/trials/combined-relapse-prediction-model-for-resectable-non-small-cell-patients-a-prospective-clinical-feasibility-trial-47080https://curecurrent.com/trials/proton-based-cardiac-sparing-accelerated-fractionated-radiotherapy-in-unresectable-nsclc-47081https://curecurrent.com/trials/application-of-carbon-dioxide-for-identifying-the-intersegmental-plane-in-thoracoscopic-segmentectomy-47082https://curecurrent.com/trials/egf816-and-trametinib-in-patients-with-non-small-cell-lung-cancer-harboring-activating-egfr-mutations-47083https://curecurrent.com/trials/a-non-interventional-pilot-study-on-machine-learning-for-ild-detection-based-on-the-patient-data-from-digital-devices-in-47084https://curecurrent.com/trials/feasibility-of-an-activity-regimen-in-patients-with-advanced-stage-lung-cancer-47085https://curecurrent.com/trials/non-invasive-measurement-of-pd-l1-levels-with-positron-emission-tomography-pet-in-head-and-neck-malignancies-and-intracr-47086https://curecurrent.com/trials/neoadjuvant-camrelizumab-combined-with-chemotherapy-for-resectable-stage-iiia-iiib-nsclc-47087https://curecurrent.com/trials/effect-of-3d-printed-reconstruction-system-in-size-of-left-dlt-47088https://curecurrent.com/trials/machine-learning-to-construct-an-association-model-for-lung-cancer-and-environmental-hormone-47089https://curecurrent.com/trials/the-iit-study-of-evaluation-of-p-il-2-single-agent-and-with-anti-pd-1-47090https://curecurrent.com/trials/extracellular-vesicles-infusion-treatment-for-mild-to-moderate-covid-19-47091https://curecurrent.com/trials/a-study-of-sy-3505-versus-crizotinib-in-first-line-treatment-of-patients-with-alk-positive-nsclc-47092https://curecurrent.com/trials/pbf-1129-in-patients-with-nsclc-47093https://curecurrent.com/trials/a-study-of-abbv-011-alone-and-in-combination-with-budigalimab-abbv-181-in-participants-with-relapsed-or-refractory-small-47094https://curecurrent.com/trials/evaluation-of-dual-task-performance-and-respiratory-muscle-endurance-in-patients-with-lung-cancer-47095https://curecurrent.com/trials/physical-activity-behavioral-change-intervention-in-lung-cancer-47096https://curecurrent.com/trials/osimertinib-with-or-without-savolitinib-as-1l-in-de-novo-met-egfr-nsclc-47097https://curecurrent.com/trials/model-to-predict-pcr-and-iraes-in-early-stage-non-small-cell-lung-cancer-47098https://curecurrent.com/trials/prospective-trial-on-eosinophilia-in-non-small-cell-lung-cancer-nsclc-47099https://curecurrent.com/trials/sct-i10a-or-placebo-plus-docetaxel-with-previously-treated-squamous-cell-non-small-cell-lung-cancer-47100https://curecurrent.com/trials/a-phase-iiii-study-of-al8326-in-small-cell-lung-cancer-47101https://curecurrent.com/trials/wbrt-with-hippocampal-avoidance-technique-followed-by-srt-for-extensive-stage-sclc-with-baseline-brain-metastases-47102https://curecurrent.com/trials/accelerated-radio-immunotherapy-for-lung-cancer-47103https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetics-of-oral-cpl304110-in-adult-subjects-with-advanced-solid-malignancies-47104https://curecurrent.com/trials/anti-pd-1-alone-or-combined-with-autologous-cell-therapy-in-advanced-nsclc-47105https://curecurrent.com/trials/utrecht-cohort-for-lung-cancer-outcome-reporting-and-trial-inclusion-u-color-47106https://curecurrent.com/trials/combination-of-immunotherapy-and-hyperthermia-in-advanced-malignant-mesothelioma-47107https://curecurrent.com/trials/safety-of-pentoxifylline-and-vitamin-e-with-stereotactic-ablative-radiotherapy-sabr-in-non-small-cell-lung-cancers-47108https://curecurrent.com/trials/accuracy-of-deep-learning-algorithm-for-detection-and-risk-stratification-of-lung-nodules-47109https://curecurrent.com/trials/treatment-with-bibw-2992-irreversible-inhibitor-of-egfr-and-her-2-in-non-small-cell-lung-cancer-47110https://curecurrent.com/trials/neoadjuvant-aumolertinib-in-patients-with-ai-diagnosed-egfr-mutant-high-risk-pulmonary-ground-glass-opacity-47111https://curecurrent.com/trials/feasibility-and-safety-of-nintedanib-in-combination-with-nivolumab-in-pretreated-patients-with-advanced-or-metastatic-ns-47112https://curecurrent.com/trials/a-trial-of-radial-ebus-versus-vbn-for-the-peripheral-pulmonary-lesions-47113https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetics-of-a-monoclonal-antibody-specific-to-b-and-t-lymphocyte-attenuator-btla-as-mono-47114https://curecurrent.com/trials/a-study-of-ramucirumab-ly3009806-or-necitumumab-ly3012211-plus-osimertinib-in-participants-with-lung-cancer-47115https://curecurrent.com/trials/diagnostic-yeld-of-ultrathin-bronchoscopy-in-peripheral-pulmonary-lesions-47116https://curecurrent.com/trials/biomarker-analysis-in-high-pd-l1-expressing-nsclc-patients-treated-with-pd-1-pd-l1-based-therapy-with-or-without-the-add-47117https://curecurrent.com/trials/evaluation-of-deployment-capability-and-accuracy-of-an-outside-the-scope-ots-detachable-catheter-system-for-ablation-of-47118https://curecurrent.com/trials/resilience-measurement-in-older-adults-with-late-stage-lung-cancer-47119https://curecurrent.com/trials/generation-of-lung-tumor-organoids-from-patients-undergoing-diagnostic-bronchoscopy-47120https://curecurrent.com/trials/a-study-of-carboplatin-plus-etoposide-with-or-without-zkab001-anti-pd-l1-antibody-in-patients-with-es-sclc-47121https://curecurrent.com/trials/ose2101-versus-chemotherapy-in-hla-a2-positive-patients-with-advanced-nsclc-after-immune-checkpoint-inhibitor-failure-47122https://curecurrent.com/trials/phase-i-evaluation-of-immunotoxin-lmb-100-administered-by-normothermic-intrapleural-perfusion-following-cytoreductive-su-47123https://curecurrent.com/trials/neoadjuvant-immunotherapy-plus-chemotherapy-for-potentially-resectable-stage-iiia-iiib-non-small-cell-lung-cancer-47124https://curecurrent.com/trials/adebrelimab-and-concurrent-radiochemotherapy-as-first-line-treatment-for-extensive-stage-small-cell-lung-cancer-47125https://curecurrent.com/trials/molecular-pathologic-intra-tumoral-heterogeneity-in-malignant-pleural-mesothelioma-47126https://curecurrent.com/trials/prospective-urban-rural-epidemiology-study-47127https://curecurrent.com/trials/feasibility-study-of-radiation-therapy-with-wide-detector-4dct-scanning-for-primary-or-metastatic-lung-cancer-47128https://curecurrent.com/trials/pamiparib-bgb-290-was-used-in-egfr-tkis-resistant-non-small-cell-lung-cancer-47129https://curecurrent.com/trials/phase-iii-study-of-ty-9591-in-patients-with-locally-advanced-or-metastatic-non-small-cell-lung-cancer-fleteo-47130https://curecurrent.com/trials/the-science-of-the-art-of-palliative-care-47131https://curecurrent.com/trials/a-study-of-ty-1091-in-patients-with-advanced-solid-tumors-47132https://curecurrent.com/trials/study-to-evaluate-treatment-customized-according-to-rap80-and-brca1-in-patients-with-advanced-lung-carcinoma-47133https://curecurrent.com/trials/an-observational-study-on-predicting-the-efficacy-of-immunotherapy-for-nsclc-based-on-lirascore-47134https://curecurrent.com/trials/surgical-positioning-of-the-arm-during-thoracic-surgery-effect-on-shoulder-pain-after-surgery-47135https://curecurrent.com/trials/sbrt-rt-in-oligometastatic-stage-iv-nsclc-47136https://curecurrent.com/trials/leflunomide-or-combination-of-mek-inhibitor-and-hydroxychloroquine-for-refractory-patients-with-ras-mutations-47137https://curecurrent.com/trials/dexmedetomidine-in-thoracoscopic-surgery-opioid-sparing-strategy-47138https://curecurrent.com/trials/tislelizumab-combined-with-sitravatinib-as-consolidation-treatment-following-concurrent-chemoradiation-in-patients-with-47139https://curecurrent.com/trials/preparing-family-caregivers-to-make-medical-decisions-for-their-loved-ones-47140https://curecurrent.com/trials/neoadjuvant-sintilimab-plus-anlotinib-therapy-in-ib-iiib-resectable-non-small-cell-lung-cancer-47141https://curecurrent.com/trials/pet-adjusted-intensity-modulated-radiation-therapy-and-combination-chemotherapy-in-treating-patients-with-stage-ii-iv-no-47142https://curecurrent.com/trials/clinical-effectiveness-of-combining-mindfulness-based-stress-reduction-with-exercise-interventione-47143https://curecurrent.com/trials/bio-300-non-small-cell-lung-cancer-study-47144https://curecurrent.com/trials/development-of-a-fluorescent-visualization-system-for-non-visible-lung-cancer-nodules-47145https://curecurrent.com/trials/a-study-of-zn-e4-in-subjects-with-epidermal-growth-factor-receptor-mutated-non-small-cell-lung-cancer-47146https://curecurrent.com/trials/validation-of-rapid-on-site-diagnostics-in-early-stage-lung-cancer-sampling-with-a-higher-harmonic-generation-microscope-47147https://curecurrent.com/trials/lung-cancer-adaptive-ethos-47148https://curecurrent.com/trials/pre-operative-localization-of-ground-glass-solitary-pulmonary-nodules-47149https://curecurrent.com/trials/total-body-pet-ct-imaging-using-the-uexplorer-in-non-small-cell-lung-cancer-patients-treated-by-induction-chemotherapy-p-47150https://curecurrent.com/trials/checkpoint-inhibition-in-combination-with-an-immunoboost-of-external-beam-radiotherapy-in-solid-tumors-47151https://curecurrent.com/trials/proclaim-cx-2029-a-trial-to-find-safe-and-active-doses-of-an-investigational-drug-cx-2029-for-patients-with-solid-tumors-47152https://curecurrent.com/trials/hy1272-in-patients-with-locally-advanced-or-metastatic-solid-tumors-or-locally-advanced-or-metastatic-egfrm-nsclc-47153https://curecurrent.com/trials/dna-methylation-combined-with-artificial-intelligence-imaging-to-identify-lung-nodules-47154https://curecurrent.com/trials/a-phase-i-study-of-adagrasib-and-durvalumab-for-treatment-of-advanced-non-small-cell-lung-cancers-and-gastro-intestinal-47155https://curecurrent.com/trials/study-to-determine-the-effect-of-food-on-the-blood-levels-of-azd9291-following-oral-dosing-of-a-tablet-formulation-in-pa-47156https://curecurrent.com/trials/exploring-the-frontiers-of-neoadjuvant-therapy-for-lung-cancer-a-prospective-observational-real-world-study-47157https://curecurrent.com/trials/trial-of-consolidation-pembrolizumab-after-concurrent-chemotherapy-and-proton-reirradiation-for-thoracic-recurrences-of-47158https://curecurrent.com/trials/reveal-the-patterns-of-presentation-management-and-outcome-of-patients-with-sclc-and-stage-iii-nsclc-in-saudi-arabia-47159https://curecurrent.com/trials/ai-ebus-elastography-for-ln-staging-47160https://curecurrent.com/trials/beyond-the-lung-cancer-diagnosis-leveraging-the-oncology-clinic-setting-for-actively-smoking-family-members-47161https://curecurrent.com/trials/smet12-and-toripalimab-combined-chemotherapy-in-patients-with-egfr-positive-advanced-non-small-cell-lung-cancer-nsclc-47162https://curecurrent.com/trials/hypofractionated-image-guided-radiation-therapy-igrt-in-patients-with-stage-ii-iii-non-small-cell-lung-cancer-47163https://curecurrent.com/trials/a-clinical-study-of-pain-and-discomfort-associated-with-advanced-lung-cancer-47164https://curecurrent.com/trials/immune-response-under-immunotherapy-in-metastatic-nsclc-sputum-blood-samples-and-microbioata-study-47165https://curecurrent.com/trials/identification-of-a-predictive-metabolic-signature-of-response-to-immune-checkpoint-inhibitors-in-non-small-cell-lung-ca-47166https://curecurrent.com/trials/bioluma-biomarkers-for-nivolumab-and-ipilimumab-and-evaluation-of-the-combination-in-lung-cancer-47167https://curecurrent.com/trials/role-of-neutrophils-and-electro-bioluminescence-in-the-rehabilitation-47168https://curecurrent.com/trials/prospective-clinicogenomic-program-47169https://curecurrent.com/trials/preoperative-chemoradiotherapy-vs-chemotherapy-alone-in-nsclc-patients-47170https://curecurrent.com/trials/pet-imaging-with-18f-f-arag-in-advanced-non-small-cell-lung-cancer-nsclc-47171https://curecurrent.com/trials/covid-19-immune-response-in-patients-with-cancer-undergoing-mrna-vaccination-against-sars-cov-2-47172https://curecurrent.com/trials/efficacy-and-safety-of-ibi110-in-combination-with-sintilimab-versus-sintilimab-alone-in-neoadjuvant-and-adjuvant-therapy-47173https://curecurrent.com/trials/neoadjuvant-osimertinib-chemotherapy-for-egfr-mutant-stage-iii-nsclc-47174https://curecurrent.com/trials/stereotactic-ablative-radiotherapy-in-synchronous-and-metachronous-oligo-metastatic-non-small-cell-lung-cancer-47175https://curecurrent.com/trials/efficacy-of-targeted-therapy-combined-chemotherapy-in-advanced-egfr-positive-nsclc-patients-47176https://curecurrent.com/trials/tissue-eosinophils-in-non-small-cell-lung-cancer-the-ten-study-47177https://curecurrent.com/trials/m7824-with-ccrt-in-unresectable-stage-iii-non-small-cell-lung-cancer-nsclc-47178https://curecurrent.com/trials/mrd-guided-prognosis-prediction-and-adjuvant-treatment-based-on-ctc-and-ctdna-in-nsclc-47179https://curecurrent.com/trials/medicoeconomic-evaluation-of-two-surgical-techniques-for-lobectomy-in-the-lung-cancer-47180https://curecurrent.com/trials/a-study-of-avutometinib-vs-6766-defactinib-in-recurrent-kras-g12v-other-kras-and-braf-non-small-cell-lung-cancer-47181https://curecurrent.com/trials/study-of-vinorelbine-and-cisplatin-as-induction-therapy-with-radiotherapy-in-patients-with-unresectable-nsclc-47182https://curecurrent.com/trials/a-safety-and-efficacy-study-of-bcd-021-with-paclitaxel-and-carboplatin-compared-to-avastin-with-paclitaxel-and-carboplat-47183https://curecurrent.com/trials/sp-robotic-versus-vats-anatomical-pulmonary-resection-for-patients-with-nsclc-47184https://curecurrent.com/trials/safir02-lung-efficacy-of-targeted-drugs-guided-by-genomic-profiles-in-metastatic-nsclc-patients-47185https://curecurrent.com/trials/efficacy-and-biomarker-explanation-of-ibi-323-bevacizumab-plus-platinum-based-chemotherapy-on-alk-rearranged-nsclc-47186https://curecurrent.com/trials/golidocitinib-in-combination-with-sintilimab-for-pd-l1-selected-treatment-locally-advanced-or-metastatic-non-small-cell-47187https://curecurrent.com/trials/efficacy-and-biomarker-explanation-of-ibi-322-plus-lenvatinib-on-extensive-stage-small-cell-lung-cancer-47188https://curecurrent.com/trials/navigated-ebus-and-functional-imaging-in-lung-cancer-47189https://curecurrent.com/trials/high-dose-vitamin-a-compound-in-treating-participants-with-resectable-non-small-cell-lung-cancer-47190https://curecurrent.com/trials/evaluation-of-89zr-dfo-nimotuzumab-for-non-invasive-imaging-of-egfr-cancers-by-positron-emission-tomography-pet-47191https://curecurrent.com/trials/thoracic-consolidation-radiotherapy-for-es-sclc-treated-with-chemo-immunotherapy-47192https://curecurrent.com/trials/retrospective-study-of-radio-induced-toxicities-in-the-treatment-of-lung-cancer-with-tomotherapy-47193https://curecurrent.com/trials/covid-19-and-cancer-consortium-registry-47194https://curecurrent.com/trials/efficacy-and-safety-of-deb-bace-combined-with-pd-1-inhibitors-in-stage-ii-iii-nsclc-with-standard-treatment-failure-47195https://curecurrent.com/trials/non-risk-based-lang-cancer-screening-with-a-one-off-ldct-47196https://curecurrent.com/trials/evaluation-of-irdye800cw-nimotuzumab-in-lung-cancer-surgery-47197https://curecurrent.com/trials/collection-of-blood-samples-in-patients-with-non-small-cell-lung-cancer-47198https://curecurrent.com/trials/lung-cancer-case-registry-and-tissue-resource-47199https://curecurrent.com/trials/application-of-68ga-labeled-ace2-targeting-probe-pet-ct-imaging-in-tracing-ace2-expression-and-diagnosis-of-lung-cancer-47200https://curecurrent.com/trials/a-prehabilitation-program-to-boost-postoperative-functional-capacity-in-surgical-lung-cancer-patients-47201https://curecurrent.com/trials/serplulimab-for-patients-with-non-small-cell-lung-cancer-nsclc-with-tps-50-a-prospective-single-center-single-arm-phase-47202https://curecurrent.com/trials/a-clinical-trial-of-durvalumab-medi4736-as-1st-line-therapy-in-advanced-non-small-cell-lung-cancer-patients-47203https://curecurrent.com/trials/effect-of-neoadjuvant-anti-pd-1-immunotherapy-on-perioperative-analgesia-and-postoperative-delirium-47204https://curecurrent.com/trials/effect-of-pembrolizumab-with-or-without-carboplatin-and-paclitaxel-on-immune-response-in-patients-with-recurrent-or-stag-47205https://curecurrent.com/trials/to-assess-the-efficacy-and-safety-of-furmonertinib-in-patients-with-epidermal-growth-factor-receptor-20ins-mutation-posi-47206https://curecurrent.com/trials/ventilation-heterogeneity-prior-to-lung-resection-47207https://curecurrent.com/trials/family-caregivers-in-underserved-populations-providing-complex-cancer-care-47208https://curecurrent.com/trials/whole-brain-radiation-therapy-alone-vs-radiosurgery-for-sclc-patients-with-1-10-brain-metastases-47209https://curecurrent.com/trials/the-efficacy-and-safety-of-drug-loaded-microsphere-bronchial-artery-chemoembolization-deb-bace-combined-with-anlotinib-a-47210https://curecurrent.com/trials/covid-19-vaccine-efficacy-in-patients-with-malignant-pathologies-47211https://curecurrent.com/trials/durvalumab-medi4736-and-azd6738-combination-therapy-in-relapsed-small-cell-lung-cancer-subjects-47212https://curecurrent.com/trials/paravertebral-block-versus-thoracic-epidural-analgesia-47213https://curecurrent.com/trials/a-study-of-immunotherapy-drugs-nivolumab-and-ipilimumab-in-patients-w-resectable-malignant-peritoneal-mesothelioma-47214https://curecurrent.com/trials/olaparib-and-bevacizumab-in-relapsed-small-cell-lung-cancer-subjects-47215https://curecurrent.com/trials/tcm-constitution-pattern-types-and-disease-factors-in-primary-lung-cancer-47216https://curecurrent.com/trials/heterogeneity-of-dendritic-cells-in-colon-and-non-small-cell-lung-cancer-47217https://curecurrent.com/trials/neoadjuvant-of-tislelizumab-combined-with-chemotherapy-followed-by-surgery-in-unresectable-stage-nsclc-47218https://curecurrent.com/trials/nivolumab-and-ipilimumab-and-stereotactic-body-radiation-therapy-in-treating-patients-with-salivary-gland-cancers-47219https://curecurrent.com/trials/rc48-combined-with-egfr-or-her2-tki-for-locally-advanced-or-metastatic-nsclc-patients-with-her2-alterations-47220https://curecurrent.com/trials/trial-of-tumor-vaccine-used-for-adjuvant-therapy-in-post-radical-operation-patients-with-lung-cancer-47221https://curecurrent.com/trials/shr-1701-combined-with-fluzoparib-in-lung-squamous-cell-carcinoma-47222https://curecurrent.com/trials/synergistic-effect-of-elemene-plus-tkis-compared-with-tkis-in-egfr-mutated-advanced-nsclc-retrospective-study-47223https://curecurrent.com/trials/real-world-study-on-the-efficacy-of-ibi-322-in-combination-with-lenvatinib-for-the-treatment-of-extensive-stage-small-ce-47224https://curecurrent.com/trials/cancer-screening-smoking-cessation-and-respiratory-assessment-47225https://curecurrent.com/trials/real-world-study-on-first-line-crizotinib-in-ros1-rearranged-advanced-non-squamous-non-small-cell-lung-cancer-47226https://curecurrent.com/trials/synergistic-effect-of-elemene-plus-tkis-compared-with-tkis-in-egfr-mutated-advanced-nsclc-prospective-study-47227https://curecurrent.com/trials/a-study-exploring-efficacy-of-sibp04-in-subjects-with-non-squamous-non-small-cell-lung-cancer-47228https://curecurrent.com/trials/study-of-anlotinib-combined-with-docetaxel-in-non-driver-mutation-non-squamous-nsclc-the-save-study-47229https://curecurrent.com/trials/a-real-world-study-of-atezolizumab-in-combination-with-platinum-based-doublet-chemotherapy-as-neoadjuvant-therapy-for-re-47230https://curecurrent.com/trials/association-between-the-results-of-specific-genetic-tests-and-the-efficacy-of-targeted-therapies-in-patients-47231https://curecurrent.com/trials/chemotherapy-or-chemotherapy-plus-pd-1-antibody-in-ret-fusion-positive-advanced-nsclc-patitnts-the-poseidon-trial-47232https://curecurrent.com/trials/real-world-study-of-first-line-crizotinib-for-alk-rearranged-non-squamous-non-small-cell-lung-cancer-47233https://curecurrent.com/trials/a-study-of-sunvozertinib-combined-with-anlotinib-in-local-advanced-or-metastatic-non-small-cell-lung-cancer-47234https://curecurrent.com/trials/real-world-study-on-erlotinib-gefitinib-combined-with-bevacizumab-in-advanced-non-aquamous-non-small-cell-lung-cancer-47235https://curecurrent.com/trials/litt-and-pembrolizumab-in-recurrent-brain-metastasis-47236https://curecurrent.com/trials/i-125-seeds-implantation-in-the-treatment-of-recurrent-lung-cancer-after-radiotherapy-47237https://curecurrent.com/trials/enhancing-electronic-health-systems-to-decrease-the-burden-of-colon-cancer-lung-cancer-obesity-vaccine-preventable-illne-47238https://curecurrent.com/trials/adebrelimab-combined-with-bevacizumab-and-docetaxel-for-advanced-non-squamous-non-small-cell-lung-cancer-after-progressi-47239https://curecurrent.com/trials/erlotinib-combined-with-chemotherapy-in-tki-resistant-non-small-cell-lung-cancers-47240https://curecurrent.com/trials/atezolizumab-and-bevacizumab-in-egfr-mutant-nsclc-in-patients-with-progressive-disease-after-receiving-osimertinib-47241https://curecurrent.com/trials/cd40-agonistic-antibody-apx005m-sotigalimab-in-combination-with-nivolumab-47242https://curecurrent.com/trials/stereotactic-ablative-radiotherapy-with-nivolumab-for-early-stage-operable-non-small-cell-lung-cancer-47243https://curecurrent.com/trials/stereotactic-body-radiotherapy-for-the-treatment-of-opd-47244https://curecurrent.com/trials/binimetinib-and-palbociclib-before-surgery-for-the-treatment-of-operable-kras-positive-lung-colorectal-or-pancreatic-can-47245https://curecurrent.com/trials/lung-cancer-screening-using-dna-methylation-changes-in-circulated-tumor-and-pbmc-dna-47246https://curecurrent.com/trials/safety-and-effectiveness-of-radiofrequency-ablation-system-in-the-treatment-of-peripheral-lung-tumors-47247https://curecurrent.com/trials/segmentectomy-vs-lobectomy-47248https://curecurrent.com/trials/multimodal-monitoring-of-radiotherapy-response-in-squamous-cell-cancer-47249https://curecurrent.com/trials/stereotactic-body-radiation-therapy-for-un-biopsied-early-stage-non-small-cell-lung-cancer-47250https://curecurrent.com/trials/effects-of-cognitive-intervention-therapy-on-postoperative-delirium-47251https://curecurrent.com/trials/safety-and-dose-ranging-study-for-owl-evo1-as-a-lung-cancer-evoc-probe-evolution-47252https://curecurrent.com/trials/image-mining-and-ctdna-to-improve-risk-stratification-and-outcome-prediction-in-nsclc-applying-artificial-intelligence-47253https://curecurrent.com/trials/an-early-stage-study-to-evaluate-oba01-for-injection-in-patients-with-dr5-positive-la-mnsclc-47254https://curecurrent.com/trials/a-study-of-pembrolizumab-and-cryoablation-in-people-with-mesothelioma-47255https://curecurrent.com/trials/a-phase-clinical-study-of-adebrelimab-combined-with-chemotherapy-and-concurrent-radiotherapy-for-extensive-stage-oligome-47256https://curecurrent.com/trials/guadecitabine-in-combination-with-carboplatin-in-extensive-stage-small-cell-lung-cancer-47257https://curecurrent.com/trials/a-clinical-study-evaluating-nivolumab-containing-treatments-in-patients-with-advanced-non-small-cell-lung-cancer-after-f-47258https://curecurrent.com/trials/epidemiology-of-iga-selective-deficiency-clinical-manifestations-and-risk-of-transmission-47259https://curecurrent.com/trials/her2-positive-lung-cancer-treated-with-dedicated-drug-47260https://curecurrent.com/trials/trial-of-dasatinib-in-patients-with-advanced-cancers-harboring-ddr2-mutation-or-inactivating-b-raf-mutation-47261https://curecurrent.com/trials/perioperative-immunotherpay-versus-adjuvant-immunotherapy-for-resectable-non-small-cell-lung-cancer-47262https://curecurrent.com/trials/a-study-of-pemetrexed-maintenance-with-or-without-adxs11-001-immunotherapy-in-patients-with-human-papillomavirus-positiv-47263https://curecurrent.com/trials/pci-and-brain-mri-follow-up-vs-brain-mri-follow-up-alone-in-limited-stage-sclc-patients-47264https://curecurrent.com/trials/survival-prolongation-by-rationale-innovative-genomics-47265https://curecurrent.com/trials/risk-communication-in-african-american-smokers-47266https://curecurrent.com/trials/efficacy-of-osimertinib-in-patients-with-lung-cancer-47267https://curecurrent.com/trials/a-study-of-rc48-adc-in-subjects-with-advanced-non-small-cell-lung-cancer-47268https://curecurrent.com/trials/false-negative-rate-of-lung-percutaneous-needle-biopsy-47269https://curecurrent.com/trials/plasma-genomic-testing-in-patients-with-advanced-non-small-cell-lung-cancer-the-plan-study-47270https://curecurrent.com/trials/outcome-of-patients-with-lung-masses-who-are-treated-with-radiofrequency-ablation-rfa-47271https://curecurrent.com/trials/fraction-dose-escalation-of-hypo-fractionated-radiotherapy-in-lansclc-47272https://curecurrent.com/trials/metabolomics-predict-therapy-response-47273https://curecurrent.com/trials/stereotactic-margins-in-localized-bronchial-cancer-t1-t2a-n0-47274https://curecurrent.com/trials/study-to-assess-the-safety-and-tolerability-of-repeated-doses-of-an-investigational-new-drug-in-patients-with-cancer-and-47275https://curecurrent.com/trials/a-safety-tolerability-and-pk-study-of-dcc-2618-in-patients-with-advanced-malignancies-47276https://curecurrent.com/trials/identification-of-integrin-ab-expression-in-lung-cancer-patients-47277https://curecurrent.com/trials/a-study-of-lymph-node-metastatic-pattern-based-incorporating-tumor-location-ggo-components-and-size-for-non-small-cell-l-47278https://curecurrent.com/trials/evaluating-the-efficacy-of-atezolizumab-in-advanced-non-small-cell-lung-cancer-nsclc-47279https://curecurrent.com/trials/aimn-multicenter-study-18-f-fdg-pet-ct-with-or-without-contrast-medium-in-the-staging-and-radiation-of-lung-cancer-47280https://curecurrent.com/trials/use-of-integrated-pet-ct-as-a-first-line-staging-and-re-staging-technique-in-oncologic-patient-47281https://curecurrent.com/trials/lorlatinib-in-combination-with-chemotherapy-in-participants-with-metastatic-anaplastic-lymphoma-kinase-positive-alk-non-47282https://curecurrent.com/trials/sublobar-resection-for-adenocarcinoma-in-situ-minimally-invasive-adenocarcinoma-diagnosed-by-intraoperative-frozen-secti-47283https://curecurrent.com/trials/covid-19-vaccine-effectiveness-against-recurrent-infection-among-lung-cancer-patients-and-biomarker-research-47284https://curecurrent.com/trials/inspiratory-muscle-training-and-behavioral-support-to-alleviate-dyspnea-and-promote-walking-in-lung-cancer-survivors-a-p-47285https://curecurrent.com/trials/teas-for-the-treatment-of-pain-in-bone-metastases-of-lung-cancer-47286https://curecurrent.com/trials/iaslc-grading-system-as-a-predictor-for-egfr-tki-therapy-47287https://curecurrent.com/trials/nashville-early-diagnosis-lung-cancer-project-47288https://curecurrent.com/trials/68ga-ga-nota-rw102-pet-imaging-in-the-diagnosis-of-pd-l1-expressing-lung-cancer-47289https://curecurrent.com/trials/neoadjuvant-mpdl3280a-nab-paclitaxel-and-carboplatin-mac-in-nsclc-47290https://curecurrent.com/trials/pilot-study-of-high-risk-lung-cancer-screening-47291https://curecurrent.com/trials/microbiome-in-immunotherapy-na-ve-nsclc-patients-receiving-pd-1-l1-blockade-mip-nsclc-47292https://curecurrent.com/trials/pembrolizumab-in-untreated-extensive-sclc-47293https://curecurrent.com/trials/comparison-trial-of-white-light-autofluorescence-and-narrow-band-imaging-bronchoscopy-47294https://curecurrent.com/trials/immunotherapy-in-uncommon-and-20ins-egfr-mut-lung-cancers-47295https://curecurrent.com/trials/predictors-of-acute-and-persistent-postoperative-pain-in-lung-cancer-surgery-47296https://curecurrent.com/trials/study-of-early-nutritional-intervention-during-concurrent-chemoradiotherapy-for-local-advanced-non-small-cell-lung-cance-47297https://curecurrent.com/trials/liquid-biopsy-with-pet-ct-versus-pet-ct-alone-in-diagnosis-of-small-lung-nodules-47298https://curecurrent.com/trials/polyomic-biomarker-verification-in-adult-chronic-graft-versus-host-disease-able3-0-cttc2201-47299https://curecurrent.com/trials/analyzing-and-solving-exceptional-long-term-survivors-in-solid-tumors-with-poor-prognosis-47300https://curecurrent.com/trials/treatment-patterns-and-real-world-clinical-outcomes-in-patients-with-advanced-nsclc-and-met-exon-14-skipping-mutation-in-47301https://curecurrent.com/trials/comparing-hypo-fractionated-intensity-modulated-radiation-therapy-to-standard-fractionated-imrt-along-with-chemotherapy-47302https://curecurrent.com/trials/optimal-extent-of-pulmonary-resection-in-clinical-stage-ia-non-small-cell-lung-cancer-47303https://curecurrent.com/trials/trigriluzole-with-nivolumab-and-pembrolizumab-in-treating-patients-with-metastatic-or-unresectable-solid-malignancies-or-47304https://curecurrent.com/trials/transbronchial-vs-transthoracic-ablation-for-early-stage-peripheral-lung-cancer-47305https://curecurrent.com/trials/phase-i-ib-ii-study-of-mbg453-as-single-agent-and-in-combination-with-pdr001-in-patients-with-advanced-malignancies-47306https://curecurrent.com/trials/neoadjuvant-pd-1-antibody-plus-apatinib-or-chemotherapy-for-non-small-cell-lung-cancer-47307https://curecurrent.com/trials/cor-loco-regional-advanced-lung-cancer-treated-with-chemo-radiotherapy-cola-47308https://curecurrent.com/trials/a-randomized-phase-ii-study-of-laze-rtinib-alone-versus-lazertinib-plus-bevacizumab-for-nsclc-with-egfr-smoker-47309https://curecurrent.com/trials/study-assessing-activity-of-molecularly-matched-targeted-therapies-in-select-tumor-types-based-on-genomic-alterations-47310https://curecurrent.com/trials/international-lung-screen-trial-ilst-47311https://curecurrent.com/trials/lcl161-plus-topotecan-for-patients-with-relapsed-refractory-small-cell-lung-cancer-and-select-gynecologic-malignancies-47312https://curecurrent.com/trials/skeletal-muscle-atrophy-and-dysfunction-in-human-cancer-47313https://curecurrent.com/trials/biomarker-verification-in-pediatric-chronic-gvhd-able-2-0-ptctc-gvh-1901-study-47314https://curecurrent.com/trials/investigating-radiation-induced-injury-to-airways-and-pulmonary-vasculature-in-lung-stereotactic-ablative-body-radiother-47315https://curecurrent.com/trials/to-explore-the-effect-of-immune-induced-stereotactic-body-radiotherapy-sbrt-on-reversing-immunoresistance-in-stage-iiic-47316https://curecurrent.com/trials/digital-outpatient-services-47317https://curecurrent.com/trials/black-raspberry-nectar-for-the-prevention-of-lung-cancer-be-well-study-47318https://curecurrent.com/trials/to-evaluate-the-efficacy-of-durvalumab-anlotinib-in-terms-of-os-and-pfs-47319https://curecurrent.com/trials/deciphering-afatinib-response-and-resistance-with-intratumour-heterogeneity-47320https://curecurrent.com/trials/incidence-of-severe-covid-19-infection-in-patients-with-cll-or-b-nhl-who-received-pre-exposure-prophylaxis-with-tixagevi-47321https://curecurrent.com/trials/iloprost-in-preventing-lung-cancer-in-former-smokers-47322https://curecurrent.com/trials/rhu-pgsn-for-severe-covid-19-pneumonia-47323https://curecurrent.com/trials/systematic-symptom-identification-with-disease-specific-prom-to-assess-symptoms-of-chronic-gvhd-in-outpatient-care-in-pa-47324https://curecurrent.com/trials/a-study-of-hs-10365-in-patients-with-advanced-or-metastatic-ret-fusion-positive-non-small-cell-lung-cancer-47325https://curecurrent.com/trials/sintilimab-ibi305-plus-chemotherapy-pemetrexed-cisplatin-for-egfrm-locally-advanced-or-metastasis-non-squamous-nsclc-pat-47326https://curecurrent.com/trials/study-comparing-wx-0593-to-crizotinib-in-alk-positive-non-small-cell-lung-cancer-nsclc-patients-47327https://curecurrent.com/trials/a-study-of-ql1706-combined-with-chemotherapy-in-advanced-non-small-cell-lung-cancer-47328https://curecurrent.com/trials/osimertinib-for-nsclc-with-uncommon-egfr-mutations-47329https://curecurrent.com/trials/on-dose-efficiency-of-modern-ct-scanners-in-chest-scans-47330https://curecurrent.com/trials/real-world-analysis-of-workup-at-disease-progression-and-implementation-of-osimertinib-for-egfr-nsclc-47331https://curecurrent.com/trials/a-study-of-efbemalenograstim-alfa-injection-for-stage-iiib-or-iv-nsclc-recieving-moderate-risk-febrile-neutropenia-fn-ch-47332https://curecurrent.com/trials/integrated-discovery-of-new-immuno-molecular-actionable-biomarkers-for-tumors-with-immune-suppressed-environment-47333https://curecurrent.com/trials/prospective-collection-of-whole-blood-from-active-non-small-cell-lung-cancer-patients-for-supplemental-research-47334https://curecurrent.com/trials/ct-perfusion-imaging-in-predicting-treatment-response-in-patients-with-non-small-cell-lung-cancer-or-lung-metastases-tre-47335https://curecurrent.com/trials/a-prospective-study-of-pembrolizumab-combining-chemotherapy-in-advanced-nsclc-patients-with-egfr-exon-21-point-mutation-47336https://curecurrent.com/trials/use-of-harmonic-scalpel-to-decrease-lymphatic-and-chest-tube-drainage-after-lymph-node-dissection-with-lobectomy-47337https://curecurrent.com/trials/clinical-trial-of-sp-2577-seclidemstat-in-patients-with-relapsed-or-refractory-ewing-or-ewing-related-sarcomas-47338https://curecurrent.com/trials/application-of-mixed-reality-technique-for-percutaneous-lung-nodule-localization-a-prospective-randomized-controlled-tri-47339https://curecurrent.com/trials/long-term-follow-up-study-of-patients-receiving-atl001-47340https://curecurrent.com/trials/a-study-of-atezolizumab-in-combination-with-carboplatin-or-cisplatin-pemetrexed-compared-with-carboplatin-or-cisplatin-p-47341https://curecurrent.com/trials/recisttm-criteria-in-evaluating-the-efficacy-of-targeted-therapy-for-nsclc-47342https://curecurrent.com/trials/breath-analysis-in-early-stage-lung-cancer-using-infrared-spectroscopy-47343https://curecurrent.com/trials/postoperative-chronic-operation-related-symptoms-after-minimally-invasive-lung-surgery-47344https://curecurrent.com/trials/a-dose-escalation-and-confirmation-study-of-pt-112-in-advanced-solid-tumors-in-combination-with-avelumab-47345https://curecurrent.com/trials/analysis-of-volatile-chemicals-in-lung-cancer-screen-eligible-subjects-using-infrared-spectroscopy-47346https://curecurrent.com/trials/efficacy-and-safety-study-of-medical-thoracoscope-cryotherapy-combined-standard-first-line-treatment-of-advanced-non-sma-47347https://curecurrent.com/trials/a-study-of-ty-9591-in-advanced-non-small-cell-lung-cancer-nsclc-patients-with-egfr-positive-mutation-47348https://curecurrent.com/trials/study-to-assess-safety-tolerability-efficacy-of-pm01183-and-atezolizumab-in-patients-w-advanced-small-cell-lung-cancer-47349https://curecurrent.com/trials/study-on-the-association-of-gstp1-and-other-gene-polymorphisms-with-platinum-induced-myelosuppression-47350https://curecurrent.com/trials/study-of-cadonilimab-combined-with-bevacizumab-and-chemotherapy-for-advanced-nonsquamous-non-small-cell-lung-cancer-pati-47351https://curecurrent.com/trials/oncorine-h101-combined-with-tislelizumab-and-chemotherapy-in-previously-untreated-advanced-non-small-cell-lung-cancer-47352https://curecurrent.com/trials/a-study-of-napabucasin-bbi-608-plus-weekly-paclitaxel-versus-weekly-paclitaxel-alone-in-patients-with-advanced-previousl-47353https://curecurrent.com/trials/resiliency-among-older-adults-receiving-lung-cancer-treatment-47354https://curecurrent.com/trials/archer1050-a-study-of-dacomitinib-vs-gefitinib-in-1st-line-treatment-of-advanced-nsclc-47355https://curecurrent.com/trials/first-in-human-study-of-oral-tp-0903-a-novel-inhibitor-of-axl-kinase-in-patients-with-advanced-solid-tumors-47356https://curecurrent.com/trials/a-study-of-dsp-7888-dosing-emulsion-in-adult-patients-with-advanced-malignancies-47357https://curecurrent.com/trials/efficacy-and-safety-of-bai-combined-with-deb-bace-of-equalspheres-in-the-treatment-of-advanced-nsclc-47358https://curecurrent.com/trials/first-in-human-study-of-xmt-1536-in-cancers-likely-to-express-napi2b-47359https://curecurrent.com/trials/first-line-osimertinib-in-the-real-world-an-inter-regional-prospective-study-47360https://curecurrent.com/trials/k-sab-trial-sotorasib-followed-by-sbrt-to-1-3-lesions-in-advanced-nsclc-with-krasg12c-mutation-47361https://curecurrent.com/trials/efficacy-and-safety-of-anti-pd-1-pd-l1-treatment-uv1-vaccination-in-patients-with-non-small-cell-lung-cancer-47362https://curecurrent.com/trials/effect-of-pursed-lips-breathing-combined-with-aerobic-walking-exercise-on-oxygenation-and-activity-endurance-in-lung-can-47363https://curecurrent.com/trials/sotorasib-in-advanced-krasg12c-mutated-non-small-cell-lung-cancer-patients-with-comorbidities-47364https://curecurrent.com/trials/adebelizumab-combined-with-chemotherapy-and-radiotherapy-treat-es-sclc-47365https://curecurrent.com/trials/utidelone-versus-docetaxel-in-patients-with-locally-advanced-or-metastatic-non-small-cell-lung-cancer-47366https://curecurrent.com/trials/an-observational-study-called-rocurs-to-learn-about-covid-19-related-outcomes-in-people-with-cancer-who-are-treated-with-47367https://curecurrent.com/trials/delay-to-diagnosis-in-digestive-cancerology-by-the-general-practitioner-related-to-covid-19-pandemic-confinement-47368https://curecurrent.com/trials/early-detection-of-lung-cancer-in-patients-with-chronic-chest-diseases-47369https://curecurrent.com/trials/a-study-to-compare-the-efficacy-and-safety-of-hb1801-to-taxotere-in-advanced-non-small-cell-lung-cancer-nsclc-47370https://curecurrent.com/trials/a-non-interventional-study-on-xarelto-for-treatment-of-venous-thromboembolism-vte-and-prevention-of-recurrent-vte-in-pat-47371https://curecurrent.com/trials/the-efficacy-of-double-dose-furmonertinib-in-the-treatment-of-patients-with-slow-osimertinib-resistant-nsclc-47372https://curecurrent.com/trials/ipatasertib-and-docetaxel-in-metastatic-nsclc-patients-who-have-failed-1st-line-immunotherapy-47373https://curecurrent.com/trials/prophylactic-cerebral-irradiation-or-active-magnetic-resonance-imaging-surveillance-in-small-cell-lung-cancer-patients-p-47374https://curecurrent.com/trials/polypropylene-vs-polyglactin-in-suturing-of-the-lung-47375https://curecurrent.com/trials/pulmonary-resectable-osteosarcoma-treated-by-metastasectomy-and-pre-operative-immunotherapy-and-stereotactic-body-radiot-47376https://curecurrent.com/trials/the-lung-screening-tobacco-and-health-project-47377https://curecurrent.com/trials/a-study-of-or2805-a-monoclonal-antibody-targeting-cd163-alone-and-in-combination-with-anticancer-agents-47378https://curecurrent.com/trials/individualized-treatment-of-patients-with-advanced-nsclc-potential-application-for-circulating-tumor-cells-ctc-molecular-47379https://curecurrent.com/trials/pulmonary-resectable-metastases-of-osteosarcoma-with-anti-angiogenics-and-chemotherapy-47380https://curecurrent.com/trials/a-study-of-hs-10241-combined-with-almonertinib-versus-platinum-based-chemotherapy-in-treatment-of-advanced-nsclc-with-me-47381https://curecurrent.com/trials/chemoradiation-plus-durvalumab-followed-by-surgery-followed-by-adjuvant-durvalumab-in-patients-with-surgically-resectabl-47382https://curecurrent.com/trials/single-port-robotic-lung-anatomical-resection-47383https://curecurrent.com/trials/evaluating-the-combination-of-mk-3475-and-sterotactic-body-radiotherapy-in-patients-with-metastatic-melanoma-or-nsclc-47384https://curecurrent.com/trials/robot-assisted-vs-vats-lobectomy-for-nsclc-47385https://curecurrent.com/trials/performance-and-safety-of-biology-guided-radiotherapy-using-the-reflexion-medical-radiotherapy-system-bioguide-x-47386https://curecurrent.com/trials/a-study-of-local-envafolimab-injection-combined-with-chemotherapy-in-non-small-cell-lung-cancer-47387https://curecurrent.com/trials/tumor-treating-fields-ttfields-therapy-to-manage-brain-metastases-in-small-cell-lung-cancer-47388https://curecurrent.com/trials/safety-efficacy-and-tolerability-of-bos172738-in-patients-with-advanced-rearranged-during-transfection-ret-gene-altered-47389https://curecurrent.com/trials/local-and-peripheral-immune-responsive-landscape-induced-by-local-cryoablation-in-patients-with-lung-adenocarcinoma-47390https://curecurrent.com/trials/prevalence-of-ent-diseseas-47391https://curecurrent.com/trials/dinutuximab-in-combination-with-sargramostim-in-treating-patients-with-recurrent-osteosarcoma-47392https://curecurrent.com/trials/a-clinical-study-of-the-combination-of-anlotinib-and-aumolertinib-in-the-first-line-treatment-of-advanced-nsclc-with-egf-47393https://curecurrent.com/trials/wedge-resection-for-ground-glass-opacity-featured-lung-cancer-ectop-1020-47394https://curecurrent.com/trials/feasibility-and-safety-of-a-wireless-palpator-47395https://curecurrent.com/trials/a-phase-i-ii-study-of-ibrutinib-in-previously-treated-epidermal-growth-factor-receptor-egfr-mutant-non-small-cell-lung-c-47396https://curecurrent.com/trials/exploring-cancer-evolution-prognostic-and-predictive-biomarkers-in-egfr-mutant-nsclc-47397https://curecurrent.com/trials/assess-efficacy-and-safety-of-azd6244-in-combination-with-docetaxel-in-patients-receiving-second-line-non-small-cell-lun-47398https://curecurrent.com/trials/a-study-to-learn-about-the-tests-looking-for-a-gene-mutation-in-adults-with-lung-cancer-in-china-elegant-47399https://curecurrent.com/trials/stereotactic-body-radiation-therapy-and-avelumab-immunotherapy-for-treatment-of-malignant-mesothelioma-47400https://curecurrent.com/trials/apollo-11-consortium-of-italian-centers-involved-in-treatment-of-patients-with-lung-cancer-treated-with-innovative-thera-47401https://curecurrent.com/trials/a-biobehavioral-cognitive-treatment-for-stress-depression-and-anxiety-in-patients-with-stage-iv-lung-cancer-47402https://curecurrent.com/trials/trial-of-pevonedistat-plus-docetaxel-in-patients-with-previously-treated-advanced-non-small-cell-lung-cancer-47403https://curecurrent.com/trials/lorlatinib-as-the-first-line-treatment-in-china-advanced-alk-nsclc-47404https://curecurrent.com/trials/a-study-of-atezolizumab-with-or-without-tiragolumab-consolidation-in-limited-stage-small-cell-lung-cancer-47405https://curecurrent.com/trials/early-palliative-care-in-advanced-lung-and-gastrointestinal-malignancies-47406https://curecurrent.com/trials/registry-and-screening-tool-to-identify-children-with-asthma-likely-to-benefit-from-home-assessment-and-remediation-47407https://curecurrent.com/trials/registry-of-the-spanish-society-of-thoracic-surgery-47408https://curecurrent.com/trials/cetuxibab-to-reduce-circulating-tumor-cells-in-early-stage-nsclc-47409https://curecurrent.com/trials/analysis-of-the-immune-parameters-of-covid-19-infection-in-patients-with-multiple-myeloma-47410https://curecurrent.com/trials/afatinib-and-cetuximab-in-epidermal-growth-factor-receptor-egfr-exon-20-insertion-positive-non-small-cell-lung-cancer-47411https://curecurrent.com/trials/cns-dose-escalation-expansion-of-tepotinib-in-met-driven-nsclc-47412https://curecurrent.com/trials/a-phase-i-ii-study-of-amg-510-in-combination-with-mvasi-in-patients-with-advanced-unresectable-or-metastatic-kras-g12c-m-47413https://curecurrent.com/trials/a-real-world-study-of-mobocertinib-in-adults-with-lung-cancer-in-china-meaning-47414https://curecurrent.com/trials/fludeoxyglucose-f-18-pet-in-planning-lung-cancer-radiation-therapy-47415https://curecurrent.com/trials/erlotinib-tarceva-and-bexarotene-targretin-oral-capsules-in-advanced-cancers-of-the-aerodigestive-tract-47416https://curecurrent.com/trials/hypofractionated-radiation-therapy-after-durvalumab-and-chemotherapy-for-the-treatment-of-stage-iv-extensive-stage-small-47417https://curecurrent.com/trials/olaparib-cediranib-maleate-and-standard-chemotherapy-in-treating-patients-with-small-cell-lung-cancer-47418https://curecurrent.com/trials/a-study-osimertinib-in-patients-with-stage-4-non-small-cell-lung-cancer-with-uncommon-egfr-mutations-47419https://curecurrent.com/trials/navitoclax-and-vistusertib-in-treating-patients-with-relapsed-small-cell-lung-cancer-and-other-solid-tumors-47420https://curecurrent.com/trials/nivolumab-cabozantinib-s-malate-and-ipilimumab-in-treating-patients-with-recurrent-stage-iv-non-small-cell-lung-cancer-47421https://curecurrent.com/trials/development-and-application-of-molecular-evaluation-instrument-for-lung-cancer-diagnosis-and-treatment-47422https://curecurrent.com/trials/developing-circulating-and-imaging-biomarkers-towards-personalised-radiotherapy-in-lung-cancer-47423https://curecurrent.com/trials/epidemiologic-multicenter-prospective-study-in-advanced-nsclc-non-small-cell-lung-cancer-patients-with-pdl1-protein-deat-47424https://curecurrent.com/trials/study-evaluating-the-safety-and-the-efficacy-of-combination-of-atezolizumab-tiragolumab-and-and-stereotactic-body-radiat-47425https://curecurrent.com/trials/ph-ii-osi-774-erlotinib-tarceva-in-advanced-bronchioloalveolar-cell-lung-cancer-47426https://curecurrent.com/trials/effects-of-single-agent-niraparib-and-niraparib-plus-programmed-cell-death-1-pd-1-inhibitors-in-non-small-cell-lung-canc-47427https://curecurrent.com/trials/tivantinib-as-maintenance-treatment-in-extended-small-cell-lung-cancer-times-47428https://curecurrent.com/trials/significance-of-mrd-monitoring-in-patients-with-potentially-resectable-stage-iii-non-small-cell-lung-cancer-47429https://curecurrent.com/trials/a-study-to-assess-safety-of-nivolumab-in-routine-oncology-practice-in-china-47430https://curecurrent.com/trials/prospective-study-on-resistance-associated-mutations-in-metastatic-lung-cancer-47431https://curecurrent.com/trials/pemetrexed-disodium-in-treating-patients-with-stage-iv-non-small-cell-lung-cancer-and-ecog-performance-status-3-47432https://curecurrent.com/trials/use-peripheral-blood-proteomics-to-predict-the-treatment-response-and-toxicities-in-nsclc-immunotherapy-47433https://curecurrent.com/trials/sh-1028-tablets-versus-placebo-as-adjuvant-therapy-in-resected-stage-ii-iiib-nsclc-with-sensitizing-egfr-mutations-47434https://curecurrent.com/trials/evaluate-the-efficacy-and-safety-of-aspirin-in-combination-with-trametinib-and-dabrafenib-47435https://curecurrent.com/trials/a-study-of-yl-17231-in-patients-with-advanced-solid-tumors-47436https://curecurrent.com/trials/brazilian-lung-immunotherapy-study-47437https://curecurrent.com/trials/durvalumab-medi4736-with-or-without-sbrt-in-clinical-stage-i-ii-and-iiia-non-small-cell-lung-cancer-47438https://curecurrent.com/trials/exhaled-breath-analysis-to-predict-risk-of-symptomatic-pneumonitis-47439https://curecurrent.com/trials/umbilical-cord-blood-transplant-with-added-sugar-and-chemotherapy-and-radiation-therapy-in-treating-patients-with-leukem-47440https://curecurrent.com/trials/a-global-study-to-assess-the-effects-of-medi4736-following-concurrent-chemoradiation-in-patients-with-stage-iii-unresect-47441https://curecurrent.com/trials/early-response-evaluation-in-nsclc-patients-treated-with-immunotherapy-47442https://curecurrent.com/trials/alectinib-followed-by-concomitant-consolidation-radiation-therapy-in-advanced-nsclc-with-alk-rearrangement-a-sab-47443https://curecurrent.com/trials/remote-monitoring-of-lung-cancer-patient-reported-outcomes-using-moovcare-47444https://curecurrent.com/trials/ctdna-guided-treatment-of-early-resistance-to-targeted-treatment-47445https://curecurrent.com/trials/adjuvant-therapy-of-ensartinib-in-stage-ib-iiia-alk-positive-non-small-cell-lung-cancer-47446https://curecurrent.com/trials/savolitinib-plus-docetaxel-as-2l-in-egfr-alk-ros1-met-ex14m-wildtype-nsclc-with-met-overexpression-47447https://curecurrent.com/trials/osimertinib-resistance-in-patients-with-non-small-cell-lung-carcinoma-that-have-progressed-47448https://curecurrent.com/trials/follow-up-of-a-cohort-of-patients-with-myasthenic-syndrome-and-covid-19-infection-47449https://curecurrent.com/trials/evaluation-of-trilaciclib-in-chinese-patients-with-extensive-stage-small-cell-lung-cancer-es-sclc-for-chemotherapy-induc-47450https://curecurrent.com/trials/an-study-to-evaluate-the-safety-and-efficacy-of-copanlisib-in-combination-with-nivolumab-in-patients-with-advanced-solid-47451https://curecurrent.com/trials/piloting-pathways-with-lung-cancer-patients-47452https://curecurrent.com/trials/dietary-practices-and-locally-advanced-lung-cancer-lungdiet-47453https://curecurrent.com/trials/nimotuzumab-and-nivolumab-in-treating-patients-with-advanced-non-small-cell-lung-cancer-47454https://curecurrent.com/trials/osimertinib-cetuximab-and-tucatinib-for-the-treatment-of-egfr-mutant-stage-iv-or-recurrent-non-small-lung-cell-cancer-47455https://curecurrent.com/trials/monoclonal-antibody-therapy-in-treating-patients-with-progressive-small-cell-lung-cancer-sclc-47456https://curecurrent.com/trials/ph-2-3-study-in-subjects-with-mpm-to-assess-adi-peg-20-with-pemetrexed-and-cisplatin-47457https://curecurrent.com/trials/neoadjuvant-triprizumab-and-radiotherapy-in-operable-patients-with-stage-iia-iiia-non-small-cell-lung-cancer-47458https://curecurrent.com/trials/mark-1a-series-percutaneous-microwave-ablation-for-patients-with-lung-tumor-s-47459https://curecurrent.com/trials/the-role-of-interventional-pulmonology-microbiota-and-immune-response-in-the-patient-with-lung-cancer-47460https://curecurrent.com/trials/direct-oral-anticoagulants-doacs-versus-lmwh-warfarin-for-vte-in-cancer-47461https://curecurrent.com/trials/dexamethasone-and-respiratory-function-after-mastectomy-47462https://curecurrent.com/trials/medical-nutrition-therapy-or-standard-care-in-treating-patients-with-lung-cancer-pancreatic-cancer-or-stage-iii-or-stage-47463https://curecurrent.com/trials/circulating-exosome-rna-in-lung-metastases-of-primary-high-grade-osteosarcoma-47464https://curecurrent.com/trials/combining-ici-with-sbrt-or-hypofrx-rt-for-es-nsclc-47465https://curecurrent.com/trials/fecal-microbiota-transplantation-with-immune-checkpoint-inhibitors-in-lung-cancer-47466https://curecurrent.com/trials/observational-study-of-durvalumab-in-patients-with-non-small-cell-lung-cancer-in-the-united-kingdom-47467https://curecurrent.com/trials/screening-of-postoperative-pulmonary-complications-by-electrical-impedance-tomography-47468https://curecurrent.com/trials/enabling-remote-access-to-breathe-easier-a-novel-approach-to-improve-symptom-management-47469https://curecurrent.com/trials/psychosocial-ehealth-in-advanced-lung-cancer-47470https://curecurrent.com/trials/imaging-of-t-cell-activation-with-18f-f-arag-in-advanced-non-small-cell-lung-cancer-47471https://curecurrent.com/trials/the-alterations-of-metabolic-adipo-myokines-and-body-composition-in-end-stage-lung-cancer-47472https://curecurrent.com/trials/rw-efficacy-of-sotorasib-in-kras-g12c-mutated-metastatic-nsclc-47473https://curecurrent.com/trials/lung-cancer-screening-implementation-among-employees-at-lyon-hospital-47474https://curecurrent.com/trials/mediastinal-lymph-node-dissection-versus-spared-mediastinal-lymph-node-dissection-in-stage-i-ggn-nsclc-47475https://curecurrent.com/trials/htmc0435-and-temozolomide-in-treating-patients-with-small-cell-lung-cancer-47476https://curecurrent.com/trials/radiomic-signature-as-predictive-marker-of-response-to-chemoradiation-and-durvalumab-in-stage-iii-nsclc-47477https://curecurrent.com/trials/efficacy-and-safety-of-tislelizumab-for-lung-adenocarcinoma-with-asymptomatic-brain-metastatic-47478https://curecurrent.com/trials/brigatinib-in-alk-positive-nsclc-identified-via-blood-based-assays-47479https://curecurrent.com/trials/the-effects-of-using-different-anesthetics-on-the-prognosis-of-primary-tumors-and-its-mechanism-of-action-47480https://curecurrent.com/trials/chemo-immunotherapy-hypo-fractionated-rt-and-maintenance-immunotherapy-for-stage-iii-nsclc-47481https://curecurrent.com/trials/a-study-of-nivolumab-chemotherapy-or-nivolumab-ipilimumab-versus-chemotherapy-in-non-small-cell-lung-cancer-nsclc-partic-47482https://curecurrent.com/trials/goalkeeper-intelligent-information-sharing-for-children-with-medical-complexity-47483https://curecurrent.com/trials/study-of-lung-stereotactic-adaptive-ablative-radiotherapy-47484https://curecurrent.com/trials/open-video-system-in-medicine-ovid-47485https://curecurrent.com/trials/maintain-respiratory-muscle-function-and-reduce-pneumonia-risk-in-cancer-patients-47486https://curecurrent.com/trials/feasibility-adoption-and-efficacy-of-a-virtual-reality-smoking-cessation-program-for-patients-undergoing-lung-cancer-scr-47487https://curecurrent.com/trials/topotecan-hydrochloride-and-doxorubicin-hydrochloride-in-treating-relapsed-or-refractory-small-cell-lung-cancer-47488https://curecurrent.com/trials/testing-the-addition-of-an-immunotherapy-drug-atezolizumab-to-the-usual-chemotherapy-treatment-during-radiation-therapy-47489https://curecurrent.com/trials/ct-scans-in-screening-for-lung-cancer-in-current-and-former-smokers-47490https://curecurrent.com/trials/impact-of-a-new-plant-based-high-energy-oral-nutritional-supplement-on-nutritional-outcomes-in-malnourished-patients-47491https://curecurrent.com/trials/vinorelbine-tartrate-and-paclitaxel-in-treating-older-patients-with-advanced-non-small-cell-lung-cancer-47492https://curecurrent.com/trials/a-study-to-investigate-the-efficacy-and-safety-of-tislelizumab-combined-with-sitravatinib-as-maintenance-therapy-for-es-47493https://curecurrent.com/trials/modifying-your-diet-to-support-muscle-during-cancer-treatment-47494https://curecurrent.com/trials/99mtc-h7nd-spect-ct-imaging-in-nsclc-47495https://curecurrent.com/trials/adjuvant-befotertinib-in-stage-ib-iiib-non-small-cell-lung-cancer-with-positive-egfr-sensitive-mutations-47496https://curecurrent.com/trials/osimertinib-and-bevacizumab-as-treatment-for-egfr-mutant-lung-cancers-47497https://curecurrent.com/trials/a-machine-learning-approach-to-identify-patients-with-resected-non-small-cell-lung-cancer-with-high-risk-of-relapse-47498https://curecurrent.com/trials/a-single-center-single-arm-clinical-study-on-the-treatment-of-advanced-non-small-cell-lung-cancer-with-positive-egfr-sen-47499https://curecurrent.com/trials/almonertinib-combined-with-anlotinib-as-first-line-treatment-for-advanced-non-small-cell-lung-cance-47500https://curecurrent.com/trials/a-clinical-study-of-recombinant-human-vascular-endothelial-inhibitor-in-combination-with-prag-for-advanced-refractory-no-47501https://curecurrent.com/trials/osimertinib-combined-with-aspirin-neoadjuvant-therapy-for-resectable-egfr-mutated-nsclc-patients-47502https://curecurrent.com/trials/a-study-of-combination-therapies-with-viagenpumatucel-l-hs-110-in-patients-with-non-small-cell-lung-cancer-47503https://curecurrent.com/trials/rosmalip-for-cancer-infections-prevention-47504https://curecurrent.com/trials/trial-of-radiation-and-gene-therapy-before-nivolumab-for-metastatic-non-small-cell-lung-carcinoma-and-uveal-melanoma-47505https://curecurrent.com/trials/study-of-pembrolizumab-mk-3475-versus-platinum-based-chemotherapy-for-participants-with-programmed-cell-death-ligand-1-p-47506https://curecurrent.com/trials/testing-informed-decision-making-in-lung-cancer-screening-47507https://curecurrent.com/trials/study-of-anti-telomerase-t-cd4-immunity-in-metastatic-lung-cancer-47508https://curecurrent.com/trials/observational-retro-prospective-study-on-pd1-pdl1-inhibitors-treatment-duration-in-patients-with-nsclc-47509https://curecurrent.com/trials/connect-smoking-cessation-and-lung-cancer-screening-47510https://curecurrent.com/trials/sintilimab-combined-with-anlotinib-in-advanced-nsclc-with-egfr-uncommon-mutations-47511https://curecurrent.com/trials/study-of-cytoreductive-surgery-and-hyperthermic-intrathoracic-pleural-chemotherapy-hitc-with-escalating-doses-for-childr-47512https://curecurrent.com/trials/role-of-bronchoscope-in-diagnosis-of-lung-cancer-47513https://curecurrent.com/trials/efficacy-and-safety-of-nab-paclitaxel-lenvatinib-pembrolizumab-as-second-line-treatment-in-advanced-nsclc-patients-47514https://curecurrent.com/trials/mcbct-in-combination-with-enb-for-the-diagnosis-of-ppns-47515https://curecurrent.com/trials/pembrolizumab-and-itacitinib-incb039110-for-non-small-cell-lung-cancer-47516https://curecurrent.com/trials/breathomics-may-it-become-an-affordable-new-tool-for-early-diagnosis-and-screening-of-lung-cancer-47517https://curecurrent.com/trials/phase-1-2-study-to-evaluate-the-safety-efficacy-of-inhaled-ibio123-in-severe-covid-19-illness-47518https://curecurrent.com/trials/radiotherapy-combined-with-icis-as-treatment-for-la-nsclc-after-failing-induction-immunochemotherapy-47519https://curecurrent.com/trials/feasibility-trial-of-a-personalised-nutrition-and-activity-programme-for-people-with-lung-cancer-over-65-years-47520https://curecurrent.com/trials/poziotinib-and-ramucirumab-for-the-treatment-of-egfr-exon-20-mutant-stage-iv-non-small-cell-lung-cancer-47521https://curecurrent.com/trials/neoadjuvant-immunotherapy-for-stage-iii-non-small-cell-lung-cancer-47522https://curecurrent.com/trials/emulation-of-the-keynote-189-trial-using-electronic-health-records-47523https://curecurrent.com/trials/consolidation-pembrolizumab-following-chemoradiation-in-patients-with-inoperable-unresectable-stage-iii-nsclc-47524https://curecurrent.com/trials/remifentanil-target-controlled-infusion-versus-standard-of-care-for-conscious-sedation-during-ebus-tbna-47525https://curecurrent.com/trials/observational-cohort-study-of-advanced-non-small-cell-lung-cancer-captra-lung-47526https://curecurrent.com/trials/oncolytic-adenovirus-h101-combined-with-pd-1-inhibitors-in-patients-with-advanced-malignant-pleural-mesothelioma-47527https://curecurrent.com/trials/selective-lymph-node-dissection-for-ct1n0m0-invasive-nsclc-with-ctr-0-5-located-in-the-apical-segment-ectop-1018-47528https://curecurrent.com/trials/heterogeneously-hypofractionated-radiotherapy-for-locally-advanced-nsclc-47529https://curecurrent.com/trials/real-world-evaluation-of-the-effectiveness-of-azd7442-for-prevention-of-sars-cov-2-47530https://curecurrent.com/trials/non-small-cell-lung-cancer-with-central-nervous-system-metastasis-47531https://curecurrent.com/trials/a-spanish-medical-record-review-of-clinical-characteristics-and-outcomes-in-non-small-cell-lung-cancer-participants-with-47532https://curecurrent.com/trials/standard-of-care-lifestyle-support-for-stage-iii-nsclc-patients-47533https://curecurrent.com/trials/pharmacokinetics-of-understudied-drugs-administered-to-children-per-standard-of-care-47534https://curecurrent.com/trials/relevance-rwe-study-in-unresectable-non-small-cell-lung-cancer-stage-iii-in-canada-47535https://curecurrent.com/trials/neoadjuvant-immunochemotherapy-for-lung-cancer-47536https://curecurrent.com/trials/lazertinib-and-chemotherapy-combination-in-egfr-mutant-nsclc-patients-without-ctdna-clearance-after-lead-in-lazertinib-m-47537https://curecurrent.com/trials/nimotuzumab-for-egfr-amplified-advanced-pan-solid-tumors-47538https://curecurrent.com/trials/comprehensive-geriatric-assessment-in-elderly-non-small-cell-lung-cancer-patients-47539https://curecurrent.com/trials/the-effectiveness-of-atezolizumab-in-patients-with-locally-advanced-or-metastatic-non-small-cell-lung-cancer-after-prior-47540https://curecurrent.com/trials/a-study-of-lazertinib-as-consolidation-therapy-in-patients-with-locally-advanced-unresectable-egfr-mutant-non-small-cell-47541https://curecurrent.com/trials/progressive-relaxation-exercise-on-dyspnea-pain-and-sleep-quality-47542https://curecurrent.com/trials/comparison-of-airvo-high-flow-oxygen-therapy-with-standard-care-for-prevention-of-ppcs-after-major-h-n-surgery-47543https://curecurrent.com/trials/the-efficacy-and-safety-of-kn046-combined-with-axitinib-47544https://curecurrent.com/trials/anti-pd-1-antibody-therapies-of-camrelizumab-in-combination-with-pemetrexed-and-carboplatin-as-first-line-treatment-in-p-47545https://curecurrent.com/trials/efficacy-and-safety-of-the-anti-covid-19-vaccin-in-clinical-hematology-patients-47546https://curecurrent.com/trials/phase-ib-ii-study-of-chiauranib-in-patients-with-small-cell-lung-cancer-47547https://curecurrent.com/trials/mri-and-biomarkers-for-lung-nodules-detected-during-lung-cancer-screening-47548https://curecurrent.com/trials/neoadjuvant-pd-1-antibody-plus-chemotherapy-in-resectable-stage-iiia-n2-non-small-cell-lung-cancer-47549https://curecurrent.com/trials/safety-and-efficacy-study-of-avelumab-plus-chemotherapy-with-or-without-other-anti-cancer-immunotherapy-agents-in-patien-47550https://curecurrent.com/trials/prospective-randomized-study-efficacy-three-dimensional-reconstructions-segmentectomy-47551https://curecurrent.com/trials/the-association-of-microrna21-155-levels-with-acute-side-effects-in-patients-with-stage-iii-nsclc-with-definitive-crt-47552https://curecurrent.com/trials/radiotherapy-combined-with-almonertinib-for-stage-iii-egfr-mutated-lung-cancer-47553https://curecurrent.com/trials/study-of-mcla-129-combined-with-befotertinib-in-the-treatment-of-advanced-non-small-cell-lung-cancer-with-egfr-sensitive-47554https://curecurrent.com/trials/pdl-1-expression-on-circulating-tumor-cells-in-non-small-cell-lung-cancer-47555https://curecurrent.com/trials/bevacizumab-combined-with-fractionated-stereotactic-radiotherapy-for-1-to-10-brain-metastases-from-nsclc-47556https://curecurrent.com/trials/a-study-of-durvalumab-plus-tremelimumab-with-chemotherapy-in-untreated-es-sclc-47557https://curecurrent.com/trials/prophylactic-cranial-irradiation-versus-observation-in-stage-iv-nsclc-randomized-controlled-clinical-study-47558https://curecurrent.com/trials/an-investigational-immuno-therapy-study-of-bms-986205-given-in-combination-with-nivolumab-and-in-combination-with-both-n-47559https://curecurrent.com/trials/clearance-of-mucus-in-stents-comis-47560https://curecurrent.com/trials/phase-ii-study-of-sy-3505-in-patients-with-alk-positive-nsclc-who-have-failed-prior-second-generation-alk-tki-47561https://curecurrent.com/trials/ot-101-in-combination-with-atezolizumab-for-the-treatment-of-metastatic-or-recurrent-non-small-cell-lung-cancer-47562https://curecurrent.com/trials/vte-incidence-after-curative-colon-cancer-surgery-in-an-eras-program-47563https://curecurrent.com/trials/covid-19-prevention-and-treatment-in-cancer-a-sequential-multiple-assignment-randomised-trial-47564https://curecurrent.com/trials/phase-ii-trial-of-continuation-therapy-in-advanced-nsclc-47565https://curecurrent.com/trials/cietai-and-sequential-radiotherapy-in-squamous-lung-cancer-47566https://curecurrent.com/trials/time-to-initiated-antitumor-therapy-for-tumor-patients-with-covid19-infection-47567https://curecurrent.com/trials/a-study-of-toripalimab-pemetrexed-plus-carboplatin-in-patients-with-egfr-mutation-positive-and-t790m-negative-after-prog-47568https://curecurrent.com/trials/retrospective-external-comparator-study-of-lazertinib-as-the-2nd-line-treatment-in-patients-with-egfr-mutation-nsclc-47569https://curecurrent.com/trials/munich-me-cfs-cohort-study-47570https://curecurrent.com/trials/cediranib-paclitaxel-and-carboplatin-in-treating-patients-with-stage-iiib-or-stage-iv-non-small-cell-lung-cancer-47571https://curecurrent.com/trials/pf-00299804-in-stage-iiib-or-stage-iv-non-small-cell-lung-cancer-not-responding-to-standard-therapy-for-advanced-or-meta-47572https://curecurrent.com/trials/the-effect-of-combined-cryotherapy-and-immunotherapy-on-systemic-t-cell-changes-and-clinical-outcomes-in-metastatic-non-47573https://curecurrent.com/trials/m7824-in-combination-with-chemotherapy-in-stage-iv-non-small-cell-lung-cancer-nsclc-47574https://curecurrent.com/trials/cadonilimab-ak104-plus-chemotherapy-as-first-line-treatment-in-non-squamous-non-small-cell-lung-cancer-nsclc-patients-wi-47575https://curecurrent.com/trials/phase-iii-study-evaluating-efficacy-and-safety-of-canakinumab-in-combination-with-docetaxel-in-adult-subjects-with-non-s-47576https://curecurrent.com/trials/study-to-evaluate-sbrt-for-egfr-mutant-nsclc-patients-receiving-osimertinib-cultro-47577https://curecurrent.com/trials/ensartinib-in-non-small-cell-lung-cancer-patients-with-positive-alk-47578https://curecurrent.com/trials/monitoring-of-immune-and-microbial-reconstitution-in-hct-and-novel-immunotherapies-47579https://curecurrent.com/trials/assessing-the-safety-and-efficacy-of-plb1004-in-patients-with-advanced-non-small-cell-lung-cancer-nsclc-47580https://curecurrent.com/trials/video-assisted-surgery-in-treating-patients-with-non-small-cell-lung-cancer-47581https://curecurrent.com/trials/x-396-capsule-in-patients-with-alk-positive-non-small-cell-lung-cancer-previously-treated-with-crizotinib-47582https://curecurrent.com/trials/a-study-to-evaluate-camrelizumab-combined-with-famitinib-as-subsequent-therapy-in-patients-with-advanced-nsclc-47583https://curecurrent.com/trials/krt-232-in-subjects-with-relapsed-or-refractory-small-cell-lung-cancer-47584https://curecurrent.com/trials/emergency-department-lung-cancer-urmfg-pilot-47585https://curecurrent.com/trials/evaluating-the-combined-intervention-of-nutritional-supplementation-remune-and-exercise-in-patients-with-cancer-cachexia-47586https://curecurrent.com/trials/real-world-study-of-iruplinalkib-in-the-treatment-of-alk-positive-non-small-cell-lung-cancer-47587https://curecurrent.com/trials/docetaxel-and-cisplatin-in-treating-patients-with-stage-iii-or-stage-iv-non-small-cell-lung-cancer-47588https://curecurrent.com/trials/a-study-of-ak104-tislelizumab-with-chemotherapy-as-first-line-treatment-in-pd-l1-tps-1-non-small-cell-lung-cancer-47589https://curecurrent.com/trials/clearance-of-nnal-and-cotinine-from-second-hand-smoke-in-hair-and-urine-47590https://curecurrent.com/trials/safety-and-clinical-activity-of-nivatrotamab-in-relapsed-recurrent-metastatic-small-cell-lung-cancer-47591https://curecurrent.com/trials/indo-cyanine-green-icg-in-paediatric-oncology-mis-47592https://curecurrent.com/trials/non-interventional-prospective-study-to-determine-prevalence-of-egfr-mutations-in-non-small-cell-lung-cancer-47593https://curecurrent.com/trials/a-randomized-double-blind-placebo-controlled-phase-iii-study-to-investigate-efficacy-and-safety-of-first-line-treatment-47594https://curecurrent.com/trials/hlx301-tigit-pdl1-bispecific-in-patients-with-locally-advanced-or-metastatic-solid-tumors-47595https://curecurrent.com/trials/hlx35-egfr-4-1bb-bispecific-in-patients-with-advanced-or-metastatic-solid-tumors-47596https://curecurrent.com/trials/a-study-of-hlx10-in-combination-with-carboplatin-plus-pemetrexed-with-or-without-hlx04-compared-with-carboplatin-pemetre-47597https://curecurrent.com/trials/gen-001-live-biotherapeutic-product-and-avelumab-combination-study-for-patients-with-solid-tumors-who-have-progressed-on-47598https://curecurrent.com/trials/grn-1201-with-pembrolizumab-in-subjects-with-metastatic-pd-l1-nsclc-47599https://curecurrent.com/trials/clinicopathological-characteristics-and-prognosis-analysis-of-stage-ib-non-small-cell-lung-cancer-47600https://curecurrent.com/trials/the-development-of-a-metabolomic-test-to-diagnose-and-quantify-pancreatic-exocrine-insufficiency-the-detection-study-47601https://curecurrent.com/trials/safety-tolerability-and-efficacy-of-gls-012-and-gls-010-in-patients-with-advanced-non-small-cell-lung-cancer-47602https://curecurrent.com/trials/effect-of-tepotinib-on-the-pk-of-the-p-gp-substrate-dabigatran-etexilate-47603https://curecurrent.com/trials/sugemalimab-as-consolidation-therapy-in-patients-with-ls-sclc-following-ccrt-or-scrt-47604https://curecurrent.com/trials/radiation-in-stage-i-or-stage-ii-non-small-cell-lung-cancer-that-cannot-be-removed-by-surgery-47605https://curecurrent.com/trials/azd2171-and-standard-combination-chemotherapy-in-advanced-non-small-cell-lung-cancer-or-colorectal-cancer-47606https://curecurrent.com/trials/study-of-selumetinib-in-patients-with-previously-treated-or-untreated-advanced-metastatic-nsclc-47607https://curecurrent.com/trials/met-vegfr2-inhibitor-gsk1363089-and-erlotinib-hydrochloride-or-erlotinib-hydrochloride-alone-in-locally-advanced-or-meta-47608https://curecurrent.com/trials/reolysin-in-previously-treated-advanced-metastatic-non-small-cell-lung-cancer-receiving-standard-salvage-therapy-47609https://curecurrent.com/trials/photodynamic-therapy-using-hpph-in-treating-patients-with-stage-0-non-small-cell-lung-cancer-47610https://curecurrent.com/trials/azd2171-chemotherapy-in-advanced-nsclc-colorectal-cancer-or-other-cancer-suitable-for-treatment-with-capecitabine-non-sm-47611https://curecurrent.com/trials/study-of-selinexor-combined-with-olaparib-in-relapsed-refractory-extensive-stage-small-cell-lung-cancer-47612https://curecurrent.com/trials/mk-0646-etoposide-and-cisplatin-in-treating-patients-with-extensive-stage-small-cell-lung-cancer-47613https://curecurrent.com/trials/paclitaxel-carboplatin-with-out-cediranib-maleate-in-stage-iii-or-stage-iv-non-small-cell-lung-cancer-47614https://curecurrent.com/trials/a-phase-ii-study-of-pf-03446962-in-patients-with-advanced-malignant-pleural-mesothelioma-47615https://curecurrent.com/trials/pharmacokinetic-profiling-of-pembrolizumab-and-nivolumab-in-patients-with-melanoma-and-or-non-small-cell-lung-cancer-47616https://curecurrent.com/trials/anlotinib-hydrochloride-combined-with-ap-in-stage-iiib-iiic-iv-non-squamous-non-small-cell-lung-cancer-47617https://curecurrent.com/trials/boris-abla-o-por-micro-ondas-microwave-ablation-47618https://curecurrent.com/trials/neoadjuvant-treatment-real-world-clinical-outcomes-in-nsclc-47619https://curecurrent.com/trials/clinical-trial-to-evaluate-the-pk-and-safety-of-bcd-201-and-keytruda-in-patients-with-advanced-malignancies-47620https://curecurrent.com/trials/patient-journey-with-advanced-lung-cancer-positive-for-alk-fusion-in-brazil-47621https://curecurrent.com/trials/university-of-wisconsin-severe-asthma-research-program-iii-47622https://curecurrent.com/trials/enapotamab-vedotin-humax-axl-adc-safety-study-in-patients-with-solid-tumors-47623https://curecurrent.com/trials/regorafenib-and-methotrexate-in-treating-participants-with-recurrent-or-metastatic-kras-mutated-non-small-cell-lung-canc-47624https://curecurrent.com/trials/neoadjuvant-toripalimab-for-non-squamous-nsclc-with-egfr-mutation-47625https://curecurrent.com/trials/efficacy-and-safety-of-argon-plasma-coagulation-in-the-treatment-of-patients-with-hemoptysis-caused-by-endobronchial-mal-47626https://curecurrent.com/trials/high-flow-nasal-cannula-after-esophagectomy-47627https://curecurrent.com/trials/bintrafusp-alfa-with-chemotherapy-for-tyrosine-kinase-inhibitor-resistant-egfr-mutant-non-small-cell-lung-cancer-47628https://curecurrent.com/trials/phosphoproteomic-patterns-as-a-novel-biomarker-for-aurora-and-polo-like-kinase-inhibitors-in-non-small-cell-lung-cancer-47629https://curecurrent.com/trials/effect-of-an-oral-nutritional-supplement-on-muscle-mass-during-anticancer-treatment-47630https://curecurrent.com/trials/a-study-of-carboplatin-plus-etoposide-with-or-without-atezolizumab-in-participants-with-untreated-extensive-stage-es-sma-47631https://curecurrent.com/trials/effect-of-a-proton-pump-inhibitor-on-the-pk-of-tepotinib-47632https://curecurrent.com/trials/tirellizumab-combined-with-chemotherapy-monotherapy-for-non-small-cell-lung-cancer-47633https://curecurrent.com/trials/palliative-care-interventions-for-outpatients-newly-diagnosed-with-lung-cancer-phase-ii-47634https://curecurrent.com/trials/effectiveness-study-of-nivolumab-compared-to-chemotherapy-in-patients-with-relapsed-small-cell-lung-cancer-47635https://curecurrent.com/trials/comparison-of-segmentectomy-versus-lobectomy-for-lung-adenocarcinoma-2cm-47636https://curecurrent.com/trials/sputum-labeling-utilizing-synthetic-meso-tetra-4-carboxyphenyl-porphyrin-tcpp-for-detection-of-lung-cancer-47637https://curecurrent.com/trials/effect-of-exercise-therapy-on-psychological-state-and-clinical-prognosis-of-advanced-non-small-cell-lung-cancer-47638https://curecurrent.com/trials/a-study-of-anti-cancer-therapies-targeting-the-mapk-pathway-in-patients-with-advanced-nsclc-47639https://curecurrent.com/trials/genetic-predictors-of-benefit-to-pembrolizumab-47640https://curecurrent.com/trials/nivolumab-and-tumor-infiltrating-lymphocytes-til-in-advanced-non-small-cell-lung-cancer-47641https://curecurrent.com/trials/intraoperative-frozen-section-pathology-to-guide-surgical-treatment-for-lung-adenocarcinoma-ectop-1015-47642https://curecurrent.com/trials/study-of-efficacy-and-safety-of-ociperlimab-in-combination-with-tislelizumab-and-platinum-based-doublet-chemotherapy-as-47643https://curecurrent.com/trials/intraoperative-frozen-section-pathology-to-guide-surgical-treatment-for-lung-adenocarcinoma-ectop-1016-47644https://curecurrent.com/trials/french-national-observatory-of-the-patients-with-non-small-cell-lung-nsclc-and-molecular-testings-47645https://curecurrent.com/trials/developing-artificial-intelligence-based-algorism-to-predict-side-effects-and-symptoms-from-chemotherapy-47646https://curecurrent.com/trials/evaluation-of-correlations-between-radiologic-features-and-pathologic-subtypes-of-ggo-luad-via-wms-ectop-1011-47647https://curecurrent.com/trials/multimodal-prehabilitation-for-lung-cancer-surgery-47648https://curecurrent.com/trials/hrct-in-prediction-of-tumor-invasion-in-ggo-lung-adenocarcinoma-ectop-1008-47649https://curecurrent.com/trials/elobectomy-for-nsclc-by-vats-versus-thoracotomy-ectop-1007-47650https://curecurrent.com/trials/dose-escalation-trial-of-intra-tumoral-injection-of-nis-measles-virus-in-combination-with-atezolizumab-47651https://curecurrent.com/trials/a-study-of-incmga00012-in-participants-with-selected-solid-tumors-pod1um-203-47652https://curecurrent.com/trials/is-bone-scintigraphy-necessary-in-ct1n0m0-ggo-non-small-cell-lung-cancer-ectop-1006-47653https://curecurrent.com/trials/dose-escalation-trial-of-bexmarilimab-fp-1305-plus-pembrolizumab-in-non-small-cell-lung-cancer-47654https://curecurrent.com/trials/clinical-significance-of-hepatic-biomarkers-in-lung-cancer-patients-treated-with-immune-checkpoint-inhibitors-47655https://curecurrent.com/trials/anatomical-location-and-metastasis-pattern-of-intrapulmonary-lymph-nodes-in-nsclc-ectop-1010-47656https://curecurrent.com/trials/pemetrexed-and-platinum-use-in-the-neoadjuvant-setting-for-resectable-stage-ii-and-iiia-lung-adenocarcinoma-ectop-1002-47657https://curecurrent.com/trials/is-bronchoscopy-necessary-in-the-preoperative-workup-of-ggo-lung-cancer-ectop-1005-47658https://curecurrent.com/trials/mediastinal-staging-accuracy-of-a-selective-lymphadenectomy-strategy-in-early-stage-nsclc-ectop-1003-47659https://curecurrent.com/trials/adjuvant-chemotherapy-for-high-risk-stage-i-lung-adenocarcinoma-47660https://curecurrent.com/trials/telepalliation-digital-platform-for-patients-in-palliation-and-their-relatives-47661https://curecurrent.com/trials/a-study-of-ibi110-in-combination-with-sintilimab-and-chemotherapy-in-patients-with-untreated-extensive-stage-small-cell-47662https://curecurrent.com/trials/a-phase-ii-trial-to-evaluate-the-efficiency-and-safety-of-serplulimab-plus-chemotherapy-as-conversion-therapy-in-nsclc-47663https://curecurrent.com/trials/sotorasib-in-kras-g12c-mutated-resectable-stage-ib-iiia-nsclc-47664https://curecurrent.com/trials/interstitial-lung-disease-within-a-lung-cancer-screening-47665https://curecurrent.com/trials/sc0245-and-irinotecan-in-treating-patients-with-relapsed-extensive-stage-small-cell-lung-cancer-es-sclc-47666https://curecurrent.com/trials/cccr-nk92-cells-immunotherapy-for-non-small-cell-lung-carcinoma-47667https://curecurrent.com/trials/a-study-of-the-safety-and-tolerance-of-can04-and-pembrolizumab-in-combination-with-and-without-carboplatin-and-pemetrexe-47668https://curecurrent.com/trials/connect-oncology-needs-evaluation-tool-47669https://curecurrent.com/trials/retrospective-study-of-carebot-ai-cxr-performance-in-preclinical-practice-47670https://curecurrent.com/trials/a-phase-i-clinical-study-of-hs-20117-in-participants-with-advanced-solid-tumors-47671https://curecurrent.com/trials/the-standard-of-care-combined-with-glucocorticoid-in-elderly-people-with-mild-or-moderate-covid-19-47672https://curecurrent.com/trials/a-phase-ib-study-of-tqb2450-combined-with-anlotinib-in-patients-with-limited-stage-small-cell-lung-cancer-after-first-li-47673https://curecurrent.com/trials/preoperative-gefitinib-for-egfr-mutant-ii-iiia-nsclc-ectop-1001-47674https://curecurrent.com/trials/medi9447-alone-and-in-combination-with-medi4736-in-adult-participants-with-select-advanced-solid-tumors-47675https://curecurrent.com/trials/a-trial-of-sugemalimab-and-chemotherapy-in-unresectable-stage-iii-nsclc-47676https://curecurrent.com/trials/detection-of-abnormal-respiratory-cell-populations-in-lung-cancer-screening-patients-using-the-cypath-lung-assay-47677https://curecurrent.com/trials/neo-t-in-treating-patients-with-advanced-solid-tumors-gi-neot-03-47678https://curecurrent.com/trials/study-with-bispecific-antibody-engaging-t-cells-in-patients-with-progressive-cancer-diseases-with-positive-psca-marker-47679https://curecurrent.com/trials/multicentric-evaluation-of-covid-19-impact-on-cancer-patients-diagnostic-and-management-set-up-of-indicators-47680https://curecurrent.com/trials/m1231-in-participants-with-solid-tumors-47681https://curecurrent.com/trials/a-retrospective-study-of-radiotherapy-combined-with-egfr-tki-for-stage-iii-egfr-mutant-lung-cancer-47682https://curecurrent.com/trials/bevacizumab-or-pemetrexed-disodium-alone-or-in-combination-after-induction-therapy-in-treating-patients-with-advanced-no-47683https://curecurrent.com/trials/blp25-liposome-vaccine-and-bevacizumab-after-chemotherapy-and-radiation-therapy-in-treating-patients-with-newly-diagnose-47684https://curecurrent.com/trials/first-in-human-study-of-nvg-111-in-relapsed-refractory-ror1-malignancies-47685https://curecurrent.com/trials/interferon-alfa-isotretinoin-and-paclitaxel-in-treating-patients-with-recurrent-small-cell-lung-cancer-47686https://curecurrent.com/trials/study-to-evaluate-safety-efficacy-pharmacokinetics-and-pharmacodynamics-of-avelumab-in-combination-with-either-crizotini-47687https://curecurrent.com/trials/a-phase-2-exploratory-study-of-erlotinib-and-sndx-275-in-participants-with-non-small-cell-lung-carcinoma-who-are-progres-47688https://curecurrent.com/trials/national-network-genomic-medicine-lung-cancer-germany-47689https://curecurrent.com/trials/apatinib-and-fluzoparib-with-or-without-adebrelimab-in-previously-treated-tp53-mutant-advanced-non-small-cell-lung-cance-47690https://curecurrent.com/trials/alectinib-in-combination-with-bevacizumab-in-alk-positive-nsclc-47691https://curecurrent.com/trials/selenium-in-preventing-tumor-growth-in-patients-with-previously-resected-stage-i-non-small-cell-lung-cancer-47692https://curecurrent.com/trials/phase-ii-medi4736-in-combination-with-chemotherapy-for-first-line-treatment-of-unresectable-mesothelioma-47693https://curecurrent.com/trials/comparison-of-two-combination-chemotherapy-regimens-in-treating-patients-with-extensive-stage-small-cell-lung-cancer-47694https://curecurrent.com/trials/move-for-surgery-a-novel-preconditioning-program-47695https://curecurrent.com/trials/pemetrexed-plus-gemcitabine-or-carboplatin-for-patients-with-advanced-malignant-pleural-mesothelioma-47696https://curecurrent.com/trials/a-study-of-abp-215-versus-bevacizumab-in-chinese-subjects-with-advanced-non-squamous-non-small-cell-lung-cancer-47697https://curecurrent.com/trials/a-phase-1-2-study-of-can04-in-combination-with-different-chemotherapy-regimens-in-subjects-with-advanced-solid-tumors-47698https://curecurrent.com/trials/rbn-2397-in-combination-with-pembrolizumab-in-patients-with-sccl-47699https://curecurrent.com/trials/docetaxel-with-or-without-fgfr-inhibitor-azd4547-in-treating-patients-with-recurrent-non-small-cell-lung-cancer-47700https://curecurrent.com/trials/deep-learning-signature-for-predicting-aggressive-histological-pattern-in-resected-non-small-cell-lung-cancer-47701https://curecurrent.com/trials/lung-cancer-cryo-activation-as-a-novel-approach-to-augment-immunotherapy-efficacy-cryovate-47702https://curecurrent.com/trials/deep-learning-signature-for-predicting-complete-pathological-response-to-neoadjuvant-chemoimmunotherapy-in-non-small-cel-47703https://curecurrent.com/trials/evaluation-of-the-effect-of-training-in-the-situation-background-assessment-recommendation-sbar-tool-on-the-feeling-of-s-47704https://curecurrent.com/trials/temozolomide-and-radiation-therapy-in-treating-patients-with-brain-metastasis-secondary-to-non-small-cell-lung-cancer-47705https://curecurrent.com/trials/sorafenib-in-treating-patients-with-refractory-non-small-cell-lung-cancer-47706https://curecurrent.com/trials/a-clinical-study-of-tqb2450-injection-combined-with-chemotherapy-or-anlotinib-hydrochloride-capsule-in-the-treatment-of-47707https://curecurrent.com/trials/preoperative-evaluation-of-pulmonary-vascular-anatomy-by-holograms-47708https://curecurrent.com/trials/sintilimab-combined-with-anlotinib-as-second-or-further-line-therapy-for-ed-sclc-47709https://curecurrent.com/trials/circulating-tumor-cells-ctc-before-and-after-thoracic-resection-with-and-without-intraoperative-use-of-extracorporeal-me-47710https://curecurrent.com/trials/study-of-tarloxotinib-in-pts-with-nsclc-egfr-exon-20-insertion-her2-activating-mutations-other-solid-tumors-with-nrg1-er-47711https://curecurrent.com/trials/cetuximab-in-treating-patients-with-recurrent-or-stage-iiib-or-stage-iv-lung-cancer-47712https://curecurrent.com/trials/home-based-preoperative-exercise-training-for-lung-cancer-patients-undergoing-surgery-47713https://curecurrent.com/trials/registry-on-nen-patients-and-covid-19-47714https://curecurrent.com/trials/predicting-lung-cancer-associated-cachexia-with-pet-imaging-47715https://curecurrent.com/trials/supplementary-epidural-analgesia-in-video-assisted-thoracic-surgery-vats-the-seavats-study-47716https://curecurrent.com/trials/safety-and-immunogenicity-of-covid-19-vaccination-in-patients-with-cancer-47717https://curecurrent.com/trials/detection-of-circulating-tumor-dna-after-stereotactic-ablative-radiotherapy-in-patients-with-unbiopsied-lung-tumors-47718https://curecurrent.com/trials/livelung-impact-of-cga-in-patients-diagnosed-with-localized-nsclc-treated-with-sbrt-47719https://curecurrent.com/trials/dose-esc-exp-rmc4630-cobi-in-relapsed-refractory-solid-tumors-rmc4630-osi-in-egfr-locally-adv-meta-nsclc-47720https://curecurrent.com/trials/precision-immuno-oncology-for-advanced-non-small-cell-lung-cancer-patients-with-pd-1-ici-resistance-pioneer-biomarkers-b-47721https://curecurrent.com/trials/eribulin-mesylate-administered-in-combination-with-pemetrexed-versus-pemetrexed-alone-as-second-line-therapy-in-patients-47722https://curecurrent.com/trials/effect-of-sms-use-on-postoperative-respiratory-and-cough-exercise-compliance-47723https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-and-efficacy-of-ibi939-in-combination-with-sintilimab-in-patients-with-advan-47724https://curecurrent.com/trials/gene-therapy-in-treating-patients-with-non-small-cell-lung-cancer-that-cannot-be-surgically-removed-47725https://curecurrent.com/trials/twice-daily-sib-radiotherapy-versus-standard-radiotherapy-for-patients-with-sclc-47726https://curecurrent.com/trials/mobile-devices-to-detect-early-pneumonitis-in-stage-iii-nsclc-patients-on-durvalumab-47727https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-of-ibi939-in-combination-with-sintilimab-in-patients-with-advanced-nsclc-47728https://curecurrent.com/trials/a-phase-1-2-trial-sra737-in-combination-with-gemcitabine-and-cisplatin-or-gemcitabine-alone-in-advanced-cancer-subjects-47729https://curecurrent.com/trials/eribulin-mesylate-in-combination-with-intermittent-erlotinib-in-patients-with-previously-treated-advanced-non-small-cell-47730https://curecurrent.com/trials/envafolimab-combined-with-endostar-in-the-first-line-treatment-of-advanced-nsclc-47731https://curecurrent.com/trials/plasmodium-immunotherapy-for-lung-cancer-47732https://curecurrent.com/trials/a-randomized-open-label-multicenter-phase-3-study-to-compare-the-efficacy-and-safety-of-eribulin-with-treatment-of-physi-47733https://curecurrent.com/trials/early-detection-of-second-lung-cancer-in-patients-with-stage-i-non-small-cell-lung-cancer-47734https://curecurrent.com/trials/single-ultra-high-dose-stereotactic-body-radiation-therapy-for-early-lung-cancer-47735https://curecurrent.com/trials/early-detection-of-lung-cancer-with-machine-learning-based-on-routine-clinical-investigations-47736https://curecurrent.com/trials/envafolimab-plus-docetaxel-in-combination-with-or-without-trilaciclib-versus-docetaxel-in-advanced-nsclc-47737https://curecurrent.com/trials/harmony-study-of-blu-701-in-egfr-mutant-nsclc-47738https://curecurrent.com/trials/a-phase-1-2-trial-of-sra737-in-subjects-with-advanced-cancer-47739https://curecurrent.com/trials/lung-cancer-indicator-detection-47740https://curecurrent.com/trials/study-of-safety-and-efficacy-of-egfr-tki-egf816-in-combination-with-cmet-inhibitor-inc280-in-adult-patients-with-egfr-mu-47741https://curecurrent.com/trials/a-study-to-monitor-lung-cancer-patients-activity-and-assess-performance-status-through-a-wearable-device-47742https://curecurrent.com/trials/effectiveness-of-the-autologous-blood-patch-method-in-lung-biopsies-47743https://curecurrent.com/trials/a-real-world-study-of-covid-19-infection-in-patients-with-malignant-lymphomas-participating-in-clinical-trials-47744https://curecurrent.com/trials/cadonilimab-ak104-with-or-without-ct-as-2rd-line-treatment-for-es-sclc-47745https://curecurrent.com/trials/analysis-of-metabonomics-for-pleural-effusion-47746https://curecurrent.com/trials/prospective-data-collection-on-clinical-radiological-and-patient-reported-outcomes-after-pleural-intervention-47747https://curecurrent.com/trials/phase-i-multicenter-trial-combining-nivolumab-ipilimumab-and-hypo-fractionated-radiotherapy-for-pretreated-advanced-stag-47748https://curecurrent.com/trials/the-study-of-envafolimab-combined-with-concurrent-chemoradiotherapy-in-ls-sclc-47749https://curecurrent.com/trials/combination-chemotherapy-plus-radiation-therapy-in-treating-patients-with-stage-iii-non-small-cell-lung-cancer-that-can-47750https://curecurrent.com/trials/an-investigational-immuno-therapy-study-for-safety-of-nivolumab-in-combination-with-ipilimumab-to-treat-advanced-cancers-47751https://curecurrent.com/trials/low-dose-radiotherapy-combined-with-conventional-fractionated-radiotherapy-in-lung-cancer-after-immunotherapy-resistance-47752https://curecurrent.com/trials/vic-1911-combined-with-osimertinib-for-egfr-mutant-non-small-cell-lung-cancer-47753https://curecurrent.com/trials/comparison-of-two-combination-chemotherapy-regimens-in-treating-non-small-cell-lung-cancer-47754https://curecurrent.com/trials/combination-chemotherapy-in-treating-patients-with-advanced-non-small-cell-lung-cancer-47755https://curecurrent.com/trials/durvalumab-medi4736-in-frail-and-elder-patients-with-metastatic-nsclc-duration-47756https://curecurrent.com/trials/nodule-immunophenotyping-biomarker-for-lung-cancer-early-diagnosis-study-47757https://curecurrent.com/trials/a-study-of-cs1001-in-subjects-with-stage-iii-non-small-cell-lung-cancer-47758https://curecurrent.com/trials/establishing-clinical-utility-evidence-to-support-coverage-and-reimbursement-for-venn-biosciences-dawn-test-47759https://curecurrent.com/trials/trilaciclib-prior-to-chemotherapy-plus-tislelizumab-as-1l-treatment-for-advanced-squamous-non-small-cell-lung-cancer-47760https://curecurrent.com/trials/abscopal-effect-of-radiation-in-combination-with-rhgm-csf-for-metastatic-non-small-cell-lung-cancer-47761https://curecurrent.com/trials/admiral-trial-adaptive-mediastinal-radiation-with-chemo-immunotherapy-47762https://curecurrent.com/trials/3d-printed-reconstruction-automated-matching-system-predicts-size-of-double-lumen-tube-a-prospective-double-blinded-rand-47763https://curecurrent.com/trials/ep0057-in-combination-with-olaparib-in-relapsed-advanced-gastric-cancer-and-small-cell-lung-cancer-47764https://curecurrent.com/trials/efficacy-and-safety-of-hl-085-combined-with-vemurafenib-in-braf-v600e-patients-with-non-small-cell-lung-cancer-a-phase-i-47765https://curecurrent.com/trials/procalung-project-on-cancer-of-the-lung-47766https://curecurrent.com/trials/study-to-investigate-drp-104-in-adults-with-advanced-solid-tumors-47767https://curecurrent.com/trials/anlotinib-after-chemoradiotherapy-in-stage-iii-non-small-cell-lung-cancer-alter-l029-47768https://curecurrent.com/trials/a-study-of-preferences-for-the-first-line-treatment-of-advanced-metastatic-non-small-cell-lung-cancer-47769https://curecurrent.com/trials/fgfr-inhibitor-in-fgfr-dysregulated-cancer-47770https://curecurrent.com/trials/a-study-to-investigate-the-efficacy-and-safety-of-tislelizumab-combined-with-anlotinib-as-maintenance-therapy-for-es-scl-47771https://curecurrent.com/trials/durvalumab-and-tremelimumab-in-treating-patients-with-recurrent-stage-iv-lung-cancer-47772https://curecurrent.com/trials/a-single-arm-exploratory-study-of-neoadjuvant-therapy-47773https://curecurrent.com/trials/exploring-the-neo-adjuvant-therapy-effects-on-lung-cancer-through-monitoring-and-assessment-of-tumor-environment-47774https://curecurrent.com/trials/a-trial-of-shr-1701-with-or-without-famitinib-in-patients-with-advanced-or-metastatic-nsclc-47775https://curecurrent.com/trials/regorafenib-with-tislelizumab-in-patients-with-selected-mismatch-repair-proficient-microsatellite-stable-cancers-47776https://curecurrent.com/trials/physical-activity-intervention-for-lung-cancer-survivors-47777https://curecurrent.com/trials/the-effect-of-nutritional-risk-parameters-on-postoperative-pulmonary-complications-in-geriatric-thoracic-surgery-cases-47778https://curecurrent.com/trials/study-of-durvalumab-tremelimumab-in-nsclc-patients-after-adjuvant-treatment-47779https://curecurrent.com/trials/neoadjuvant-therapy-with-toripalimab-and-js004-combined-with-platinum-based-doublet-chemotherapy-for-resectable-or-poten-47780https://curecurrent.com/trials/determining-clinical-trial-experiences-of-lung-cancer-patients-47781https://curecurrent.com/trials/thoracic-oncogeriatric-assessment-toga-trials-47782https://curecurrent.com/trials/gr-md-02-plus-pembrolizumab-in-melanoma-non-small-cell-lung-cancer-and-squamous-cell-head-and-neck-cancer-patients-47783https://curecurrent.com/trials/cardiorespiratory-diagnostic-study-47784https://curecurrent.com/trials/acceptance-and-commitment-therapy-on-fatigue-interference-in-patients-with-advanced-lung-cancer-and-caregiver-burden-act-47785https://curecurrent.com/trials/immunotherapy-in-combination-with-chemotherapy-in-small-cell-lung-cancer-47786https://curecurrent.com/trials/application-of-sers-technology-in-clinical-diagnosis-and-prognosis-of-lung-cancer-immunotherapy-47787https://curecurrent.com/trials/live-biotherapeutic-product-mrx0518-and-pembrolizumab-combination-study-in-solid-tumors-47788https://curecurrent.com/trials/lung-map-biomarker-targeted-second-line-therapy-in-treating-patients-with-recurrent-stage-iv-squamous-cell-lung-cancer-47789https://curecurrent.com/trials/emb-01-in-combination-with-osimertinib-in-patients-with-egfr-mutant-lung-cancer-47790https://curecurrent.com/trials/retrospective-case-series-of-covid19-patients-undergoing-orthopedic-surgery-47791https://curecurrent.com/trials/exercise-in-extended-oncogene-addicted-lung-cancer-in-active-treatment-47792https://curecurrent.com/trials/oral-decitabine-and-tetrahydrouridine-as-epigenetic-priming-for-pembrolizumab-mediated-immune-checkpoint-blockade-in-pat-47793https://curecurrent.com/trials/exemestane-in-post-menopausal-women-with-nsclc-47794https://curecurrent.com/trials/manchester-lung-health-study-47795https://curecurrent.com/trials/a-dose-escalation-with-expansion-study-of-emb-01-in-participants-with-advanced-metastatic-solid-tumors-47796https://curecurrent.com/trials/surufatinib-combined-with-serplulimab-plus-chemotherapy-in-the-treatment-of-extensive-stage-small-cell-lung-cancer-47797https://curecurrent.com/trials/the-effects-of-using-different-anesthetics-on-the-prognosis-of-primary-lung-tumors-and-its-mechanism-of-action-47798https://curecurrent.com/trials/oxygen-atomizing-inhalation-of-egcg-in-the-treatment-interstitial-pneumonia-in-cancer-patients-47799https://curecurrent.com/trials/application-of-sers-technology-based-intraoperative-navigation-system-in-lung-cancer-47800https://curecurrent.com/trials/study-of-everolimus-as-maintenance-therapy-for-metastatic-nec-with-pulmonary-or-gastroenteropancreatic-origin-47801https://curecurrent.com/trials/a-phase-1-clinical-study-of-azd4635-in-patients-with-advanced-solid-malignancies-47802https://curecurrent.com/trials/a-study-of-tpx-0131-a-novel-oral-alk-tyrosine-kinase-inhibitor-in-patients-with-alk-advanced-or-metastatic-nsclc-47803https://curecurrent.com/trials/tislelizumab-combined-with-pemetrexed-carboplatin-in-patients-with-brain-metastases-of-non-squamous-nsclc-47804https://curecurrent.com/trials/study-of-anti-epidermal-growth-factor-receptor-egfr-antibody-cetuximab-in-combination-with-gemcitabine-carboplatin-in-pa-47805https://curecurrent.com/trials/the-study-observes-how-long-patients-with-non-small-cell-lung-cancer-nsclc-benefit-from-treatment-with-epidermal-growth-47806https://curecurrent.com/trials/fludeoxyglucose-f-18-pet-ct-in-predicting-response-to-chemotherapy-in-patients-with-stage-iiia-non-small-cell-lung-cance-47807https://curecurrent.com/trials/lung-map-durvalumab-as-second-line-therapy-in-treating-patients-with-recurrent-stage-iv-squamous-cell-lung-cancer-and-no-47808https://curecurrent.com/trials/cardiac-changes-after-stereotactic-radiotherapy-for-early-stage-nsclc-cancer-or-lung-metastasis-47809https://curecurrent.com/trials/atezolizumab-immunotherapy-in-patients-with-advanced-nsclc-47810https://curecurrent.com/trials/cohort-of-patients-with-nsclc-treated-with-nivolumab-under-the-atu-program-47811https://curecurrent.com/trials/lung-screen-uptake-trial-47812https://curecurrent.com/trials/french-biological-observatory-on-lung-cancer-in-never-smokers-47813https://curecurrent.com/trials/minimal-residual-disease-dynamic-monitoring-in-first-line-serplulimab-plus-chemotherapy-in-treatment-of-extensive-small-47814https://curecurrent.com/trials/a-prospective-cohort-study-of-chinese-patients-with-pulmonary-nodules-prediction-of-lung-cancer-using-noninvasive-biomar-47815https://curecurrent.com/trials/diagnostic-and-monitoring-significance-of-ctdna-methylation-analysis-by-ngs-in-benign-and-malignant-pulmonary-nodules-47816https://curecurrent.com/trials/description-of-clinical-anatomical-features-and-long-term-follow-up-for-patients-with-alk-rearrangements-47817https://curecurrent.com/trials/efficacy-of-treatment-sequences-in-patients-with-non-small-cell-lung-cancer-receiving-lorlatinib-47818https://curecurrent.com/trials/s0819-carboplatin-and-paclitaxel-with-or-without-bevacizumab-and-or-cetuximab-in-treating-patients-with-stage-iv-or-recu-47819https://curecurrent.com/trials/narrow-band-imaging-nbi-under-electronic-bronchoscope-in-lung-cancer-47820https://curecurrent.com/trials/maintenance-chemotherapy-versus-consolidative-stereotactic-body-radiation-therapy-sbrt-plus-maintenance-chemotherapy-for-47821https://curecurrent.com/trials/carboplatin-nab-paclitaxel-and-pembrolizumab-in-nsclc-47822https://curecurrent.com/trials/pulsed-low-dose-rate-radiation-with-concurrent-chemotherapy-for-non-small-cell-lung-cancer-and-esophageal-cancer-47823https://curecurrent.com/trials/evaluation-of-a-remotely-guided-physical-preparation-by-a-physical-activity-teacher-adapted-with-the-help-of-a-smartwatc-47824https://curecurrent.com/trials/combination-chemotherapy-and-bevacizumab-in-treating-patients-with-advanced-neuroendocrine-tumors-47825https://curecurrent.com/trials/a-trial-of-shr-1701-with-or-without-chemotherapy-in-patients-with-stage-iii-nsclc-47826https://curecurrent.com/trials/a-study-of-oncobax-ak-in-patients-with-advanced-solid-tumors-47827https://curecurrent.com/trials/immune-responses-in-oncology-patients-to-novel-coronavirus-vaccines-iroc-47828https://curecurrent.com/trials/the-efficiency-of-surgery-and-radiotherapy-after-shr-1316-adebrelimab-and-platinum-containing-doublet-induction-therapy-47829https://curecurrent.com/trials/to-evaluate-the-efficacy-and-safety-of-tqb3728-tablets-in-sequential-maintenance-of-tqb2450-injection-therapy-in-patient-47830https://curecurrent.com/trials/evaluation-of-the-quality-of-life-of-patients-with-metastatic-non-small-cell-lung-cancer-with-supplementary-therapy-with-47831https://curecurrent.com/trials/temodar-plus-tyrosine-kinase-inhibitors-for-progressive-cns-disease-47832https://curecurrent.com/trials/achieving-value-in-cancer-diagnostics-blood-versus-tissue-molecular-profiling-a-prospective-canadian-study-47833https://curecurrent.com/trials/three-dimensional-fluoroscopic-guidance-during-transbronchial-cryobiopsy-47834https://curecurrent.com/trials/phase-ib-study-of-stereotactic-body-radiotherapy-sbrt-in-oligometastatic-non-small-lung-cancer-nsclc-with-dual-immune-ch-47835https://curecurrent.com/trials/immunotherapy-by-nivolumab-for-hiv-patients-47836https://curecurrent.com/trials/feasibility-of-a-hybrid-delivery-of-home-based-cluster-set-resistance-training-in-lung-cancer-47837https://curecurrent.com/trials/unito-001-study-in-hrr-pdl1-positive-mpm-nsclc-47838https://curecurrent.com/trials/a-randomised-trial-of-pulmonary-metastasectomy-in-colorectal-cancer-47839https://curecurrent.com/trials/serum-exosomal-mirna-predicting-the-therapeutic-efficiency-in-lung-squamous-carcinoma-47840https://curecurrent.com/trials/phase-ii-trial-of-induction-chemotherapy-and-chemoradiotherapy-plus-minus-durvalumab-and-consolidation-immunotherapy-in-47841https://curecurrent.com/trials/tai-chi-and-aerobic-exercise-to-improve-emotional-symptom-cluster-in-late-stage-lung-cancer-patients-47842https://curecurrent.com/trials/women-helping-women-lung-cancer-screening-47843https://curecurrent.com/trials/advanced-data-aided-medicine-part-lung-cancer-47844https://curecurrent.com/trials/quantitative-diaphragmatic-ultrasound-evaluation-in-pleural-effusions-a-feasability-study-47845https://curecurrent.com/trials/italian-lung-cancer-observational-study-47846https://curecurrent.com/trials/a-phase-iii-trial-of-neoadjuvant-sintilimab-and-chemotherapy-for-nsclc-harboring-no-driver-mutations-47847https://curecurrent.com/trials/study-of-asn003-in-subjects-with-advanced-solid-tumors-47848https://curecurrent.com/trials/attenuation-of-the-hemodynamic-response-to-double-lumen-endotracheal-intubation-with-nebulized-lidocaine-47849https://curecurrent.com/trials/patient-centered-intervention-to-reduce-cancer-patients-financial-toxicity-47850https://curecurrent.com/trials/immune-response-to-covid-19-vaccine-in-immunotherapy-io-and-non-io-treated-cancer-patients-47851https://curecurrent.com/trials/expanded-evaluation-of-the-survivorship-wellness-group-program-in-the-context-of-covid-19-and-telehealth-47852https://curecurrent.com/trials/pd-l1-antibody-tqb2450-plus-chemotherapy-for-previously-untreated-limited-stage-small-cell-lung-cancer-47853https://curecurrent.com/trials/hydromorphone-for-perioperative-analgesia-in-lung-tumor-ablation-parallel-controlled-47854https://curecurrent.com/trials/disitamab-vedotin-combined-therapy-for-locally-advanced-or-metastatic-nsclc-patients-with-her2-alterations-47855https://curecurrent.com/trials/radical-treatment-of-synchronous-oligometastatic-non-small-cell-lung-carcinoma-47856https://curecurrent.com/trials/trametinib-combination-chemotherapy-and-radiation-therapy-in-treating-patients-with-stage-iii-non-small-cell-lung-cancer-47857https://curecurrent.com/trials/g1t38-a-cdk-4-6-inhibitor-in-combination-with-osimertinib-in-egfr-mutant-non-small-cell-lung-cancer-47858https://curecurrent.com/trials/cisplatin-pemetrexed-disodium-and-radiation-therapy-followed-by-docetaxel-in-treating-patients-with-stage-iii-non-small-47859https://curecurrent.com/trials/radiosurgery-plus-novottf-200a-for-metastatic-small-cell-lung-cancer-to-the-brain-47860https://curecurrent.com/trials/cva21-and-pembrolizumab-in-nsclc-bladder-cancer-vla-009-storm-keynote-200-47861https://curecurrent.com/trials/pediatrics-hot-covid-19-database-in-ny-tristate-47862https://curecurrent.com/trials/multimodalitic-imaging-in-the-n-stage-of-lung-cancer-47863https://curecurrent.com/trials/enhanced-monitoring-for-better-recovery-and-cancer-experience-in-greater-manchester-47864https://curecurrent.com/trials/epacadostat-incb24360-in-combination-with-sirolimus-in-advanced-malignancy-47865https://curecurrent.com/trials/pilot-study-of-pd-1inhibitor-tislelizumab-plus-chemotherapy-as-neoadjuvant-therapy-for-limited-stage-small-cell-lung-can-47866https://curecurrent.com/trials/toripalimab-in-combination-with-chemotherapy-and-antiangiogenic-agents-in-patients-with-non-small-cell-lung-cancer-after-47867https://curecurrent.com/trials/personalised-diet-exercise-and-emotional-support-for-lung-cancer-patients-having-chemotherapy-radiotherapy-or-immunother-47868https://curecurrent.com/trials/hippocampal-sparing-prophylactic-cranial-irradiation-in-pathologically-nodal-positive-non-small-cell-lung-cancer-47869https://curecurrent.com/trials/safety-study-of-sea-cd40-in-cancer-patients-47870https://curecurrent.com/trials/concurrent-nab-p-carboplatin-and-thoracic-radiotherapy-in-squamous-cell-lung-cancer-47871https://curecurrent.com/trials/project-peer-understanding-the-lung-cancer-patient-experience-in-the-real-world-setting-47872https://curecurrent.com/trials/effect-of-mirtazapine-versus-placebo-in-patients-with-non-small-cell-lung-cancer-and-anorexia-47873https://curecurrent.com/trials/buparlisib-gemcitabine-hydrochloride-and-cisplatin-in-treating-patients-with-advanced-solid-tumors-47874https://curecurrent.com/trials/impact-of-the-covid-19-epidemic-on-the-hospital-journey-of-patients-with-cancer-of-the-digestive-system-47875https://curecurrent.com/trials/prophylactic-cranial-irradiation-in-patients-with-lung-adenocarcinoma-with-high-risk-of-brain-metastasis-47876https://curecurrent.com/trials/adaptive-pet-study-47877https://curecurrent.com/trials/hyperpolarized-noble-gas-mri-detection-of-radiation-induced-lung-injury-47878https://curecurrent.com/trials/adjuvant-chemotherapy-combined-with-camrelizumab-for-a-a-nsclc-patients-47879https://curecurrent.com/trials/d-0316-first-time-in-patients-ascending-dose-study-47880https://curecurrent.com/trials/curative-effect-and-quality-of-life-between-uniportal-and-open-sleeve-lobectomy-for-central-type-lung-cancer-47881https://curecurrent.com/trials/program-on-lung-cancer-screening-and-tobacco-cessation-47882https://curecurrent.com/trials/kn046-plus-lenvatinib-in-subject-with-advanced-non-small-cell-lung-cancer-in-the-failure-of-anti-pd-l-1-agent-47883https://curecurrent.com/trials/dry-pleurodesis-with-talcum-and-afatinib-is-used-to-treat-patients-with-non-small-cell-lung-carcinoma-47884https://curecurrent.com/trials/sabre-a-single-arm-prospective-study-measuring-safety-and-tolerability-of-sars-cov-2-neutralising-antibodies-in-high-ris-47885https://curecurrent.com/trials/radiation-and-immune-checkpoints-blockade-in-metastatic-nsclc-bms-ca209-632-47886https://curecurrent.com/trials/almonertinib-in-the-first-line-treatment-of-patients-of-nsclc-with-poor-performance-status-47887https://curecurrent.com/trials/giving-information-systematically-and-transparently-in-lung-and-gi-cancer-phase-2-47888https://curecurrent.com/trials/mobile-health-study-and-enhanced-symptom-monitoring-in-covid-19-cancer-patients-47889https://curecurrent.com/trials/giving-information-systematically-and-transparently-in-lung-and-gi-cancer-phase-1-47890https://curecurrent.com/trials/evolution-of-the-heart-function-when-monitoring-immunotherapies-anti-cancerous-inhibiting-pd-1-47891https://curecurrent.com/trials/aumolertinib-adjuvant-therapy-of-resectable-stage-i-egfrm-nsclc-with-high-grade-patterns-47892https://curecurrent.com/trials/non-small-cell-lung-cancer-trial-of-durvalumab-and-tremelimumab-in-advanced-epidermal-growth-factor-receptor-egfr-mutant-47893https://curecurrent.com/trials/a-study-to-evaluate-safety-and-efficacy-of-multiple-dosing-with-vb10-neo-and-bempegaldesleukin-nktr-214-immunotherapy-in-47894https://curecurrent.com/trials/personalized-intervention-program-tobacco-treatment-for-patients-at-risk-for-lung-cancer-pip-47895https://curecurrent.com/trials/safety-and-efficacy-of-xmab18087-pembrolizumab-in-advanced-merkel-cell-carcinoma-or-extensive-stage-small-cell-lung-canc-47896https://curecurrent.com/trials/ctdna-mrd-in-stage-iiib-c-nsclc-patients-treated-with-induction-chemoimmunotherapy-47897https://curecurrent.com/trials/radiomics-for-prediction-of-lung-cancer-biology-47898https://curecurrent.com/trials/first-line-treatment-with-dacomitinib-plus-anlotinib-for-patients-with-advanced-nsclc-with-egfr-21l858r-mutations-47899https://curecurrent.com/trials/ai-prediction-model-and-risk-stratification-for-lung-metastasis-in-colorectal-cancer-47900https://curecurrent.com/trials/a-study-of-brigatinib-to-treat-adults-with-anaplastic-lymphoma-kinase-alk-positive-metastatic-non-small-cell-lung-cancer-47901https://curecurrent.com/trials/advanced-patient-monitoring-and-a-i-supported-outcomes-assessment-in-lung-cancer-using-internet-of-things-technologies-a-47902https://curecurrent.com/trials/expressiona-and-diagnostic-potential-of-mirnas-in-nsclc-47903https://curecurrent.com/trials/novel-optical-surface-image-guidance-system-for-beam-gated-online-adaptive-sbrt-delivery-in-mobile-lower-lung-and-upper-47904https://curecurrent.com/trials/multidimensional-evaluation-of-daily-living-activities-and-quality-of-life-in-lung-cancer-patients-47905https://curecurrent.com/trials/irx-2-regimen-combined-with-nivolumab-in-recurrent-metastatic-solid-tumors-47906https://curecurrent.com/trials/covid-19-immunogenicity-of-a-third-dose-of-mrna-1273-vaccine-among-cancer-patients-47907https://curecurrent.com/trials/trilaciclib-a-cdk-4-6-inhibitor-in-patients-receiving-docetaxel-for-metastatic-non-small-cell-lung-cancer-nsclc-preserve-47908https://curecurrent.com/trials/furmonertinib-in-patients-with-leptomeningeal-metastases-associated-with-egfr-mutated-nsclc-47909https://curecurrent.com/trials/clinical-study-of-personalized-mrna-vaccine-encoding-neoantigen-in-patients-with-advanced-esophageal-cancer-and-non-smal-47910https://curecurrent.com/trials/quest-for-tumour-evolution-of-non-small-cell-lung-cancer-47911https://curecurrent.com/trials/lung-cancer-exercise-and-force-development-47912https://curecurrent.com/trials/intensified-follow-up-of-lung-cancer-using-weekly-questionnaires-via-the-internet-47913https://curecurrent.com/trials/a-retrospective-study-of-egfr-tkis-gefitinib-erlotinib-and-osimertinib-in-nsclc-patients-treatment-47914https://curecurrent.com/trials/phase-i-ii-study-of-sy-5007-a-ret-inhibitor-in-patients-with-ret-altered-advanced-solid-tumor-47915https://curecurrent.com/trials/immunogenicity-and-safety-of-covid-19-vaccine-in-cancer-patients-47916https://curecurrent.com/trials/colorectal-pulmonary-metastases-pulmonary-metastasectomy-versus-stereotactic-ablative-radiotherapy-47917https://curecurrent.com/trials/a-study-of-prevalence-of-her3-expression-in-non-small-cell-lung-cancer-47918https://curecurrent.com/trials/outcomes-with-immune-checkpoint-inhibitor-for-patients-with-non-small-cell-lung-cancer-and-stable-brain-metastases-47919https://curecurrent.com/trials/a-phase-ib-ii-clinical-trial-to-evaluate-the-safety-and-efficacy-of-hlx208-hlx10-in-nsclc-with-braf-v600e-mutation-47920https://curecurrent.com/trials/metabolism-of-nnk-among-african-americans-47921https://curecurrent.com/trials/evaluation-of-the-safety-and-effectiveness-of-percutaneous-and-transbronchial-argon-helium-cryoablation-47922https://curecurrent.com/trials/imm2902-in-patients-with-advanced-solid-tumors-expressing-her2-47923https://curecurrent.com/trials/assessment-of-exhaled-breath-condensate-hydrogen-peroxide-ebc-h2o2-as-measured-using-a-new-device-inflammacheck-in-patie-47924https://curecurrent.com/trials/pd-l2-targeting-nanobody-radiotracer-for-pet-imaging-of-solid-tumor-47925https://curecurrent.com/trials/irae-prediction-of-anti-pd-1-l1-in-lung-cancer-47926https://curecurrent.com/trials/to-evaluate-the-correlation-between-the-results-of-specific-gene-testing-and-the-efficacy-of-targeted-therapy-in-patient-47927https://curecurrent.com/trials/lung-cancer-multi-omics-digital-human-avatars-for-integrating-precision-medicine-into-clinical-practice-47928https://curecurrent.com/trials/study-to-investigate-the-efficacy-and-safety-of-wx-0593-in-alk-positive-non-small-cell-lung-cancer-nsclc-patients-47929https://curecurrent.com/trials/real-world-therapy-of-alk-positive-nsclc-in-sweden-the-sequencing-of-alk-tyrosine-kinase-inhibitor-drugs-and-their-thera-47930https://curecurrent.com/trials/patient-navigation-for-lung-cancer-screening-in-an-urban-safety-net-system-47931https://curecurrent.com/trials/prospective-study-to-evaluate-the-blood-kinetics-of-immune-cells-and-immunosuppressive-cytokines-after-exposure-to-an-im-47932https://curecurrent.com/trials/stereotactic-radiotherapy-with-different-fractionation-modes-for-the-early-lung-cancer-47933https://curecurrent.com/trials/efficacy-and-safety-of-pvt-1-treatment-in-patients-with-advanced-non-small-cell-lung-cancer-47934https://curecurrent.com/trials/armatinib-alone-or-in-combination-with-srt-for-brain-metastases-egfr-mutated-non-small-cell-lung-cancer-47935https://curecurrent.com/trials/nivolumab-in-combination-with-ipilimumab-part-1-nivolumab-plus-ipilimumab-in-combination-with-chemotherapy-part-2-as-fir-47936https://curecurrent.com/trials/yk-029a-as-first-line-treatment-versus-platinum-based-chemotherapy-for-non-small-cell-lung-cancer-nsclc-with-egfr-exon-2-47937https://curecurrent.com/trials/neoadjuvant-immunotherapy-in-rare-mutations-localized-nsclc-47938https://curecurrent.com/trials/clinical-study-to-compare-the-pharmacokinetics-and-safety-of-ramucirumab-injection-with-cyramza-in-healthy-male-voluntee-47939https://curecurrent.com/trials/raman-spectroscopic-analysis-of-bronchoscopic-biopsy-for-diagnosing-lung-cancer-47940https://curecurrent.com/trials/re-induction-after-initial-response-with-immune-therapy-with-radiotherapy-in-lung-cancer-47941https://curecurrent.com/trials/panomic-approach-to-immune-connected-assays-in-small-cell-lung-cancer-47942https://curecurrent.com/trials/treatment-of-advanced-solid-tumors-with-neo-t-gi-neot-02-47943https://curecurrent.com/trials/genomic-study-in-non-small-cell-lung-cancer-brain-metastasis-47944https://curecurrent.com/trials/study-of-atezolizumab-combination-carboplatin-paclitaxel-bevacizumab-in-egrf-mutation-or-alk-translocation-nsclc-47945https://curecurrent.com/trials/retrospective-chart-review-and-historical-comparison-of-capmatinib-vs-standard-of-care-for-german-adult-patients-with-lo-47946https://curecurrent.com/trials/examining-clinical-trial-participation-for-small-cell-lung-cancer-patients-47947https://curecurrent.com/trials/trial-involving-subjects-over-70-years-of-age-with-non-small-cell-lung-cancer-of-stage-iv-and-comparing-a-classical-stra-47948https://curecurrent.com/trials/lung-tumor-protein-synthesis-rates-in-lung-cancer-patients-47949https://curecurrent.com/trials/a-translational-study-investigating-pd-l1-expression-after-radiotherapy-for-non-small-cell-lung-cancer-47950https://curecurrent.com/trials/a-study-to-assess-the-impact-of-an-artificial-intelligence-ai-system-on-chest-x-ray-reporting-47951https://curecurrent.com/trials/foundation-and-clinical-about-the-expression-of-pd-1-in-peripheral-blood-t-lymphocytes-47952https://curecurrent.com/trials/combination-immunotherapy-ipilimumab-nivolumab-dendritic-cell-p53-vac-patients-with-small-cell-lung-cancer-sclc-47953https://curecurrent.com/trials/efficacy-safety-study-of-lorlatinib-in-alk-ros1-metastatic-nsclc-patients-with-compassionate-use-treatment-47954https://curecurrent.com/trials/pd-l1-targeting-nanobody-probe-for-pet-imaging-of-solid-tumor-47955https://curecurrent.com/trials/osimertinib-combined-with-bevacizumab-in-the-treatment-epidermal-growth-factor-receptor-egfr-exon-20-insertions-metastat-47956https://curecurrent.com/trials/minirigid-versus-conventional-rigid-thoracoscopy-in-undiagnosed-pleural-effusions-47957https://curecurrent.com/trials/phase-ii-study-of-afatinib-plus-bevacizumab-in-the-treatment-epidermal-growth-factor-receptor-egfr-exon-g719x-s768i-and-47958https://curecurrent.com/trials/kebi-cyto-study-use-of-the-biocartis-idylla-47959https://curecurrent.com/trials/a-trial-of-gefitinib-in-combination-with-bkm120-in-patients-with-advanced-non-small-cell-lung-cancer-with-enrichment-for-47960https://curecurrent.com/trials/mechanism-of-response-to-imfinzi-neoadjuvant-therapy-in-non-small-cell-lung-cancer-patients-based-on-multiple-omics-mode-47961https://curecurrent.com/trials/educating-quitline-callers-about-lung-cancer-screening-47962https://curecurrent.com/trials/osimertinib-combined-with-bevacizumab-in-patients-with-brain-metastasis-epidermal-growth-factor-receptor-egfr-mutation-p-47963https://curecurrent.com/trials/dna-repair-and-genetic-susceptibility-to-lung-cancer-47964https://curecurrent.com/trials/maintenance-therapy-for-small-cell-lung-cancer-47965https://curecurrent.com/trials/investigating-the-biomarkers-in-tumor-and-peripheral-blood-to-evaluate-the-efficacy-of-cancer-immunotherapy-in-chest-can-47966https://curecurrent.com/trials/pre-radiotherapy-daily-exercise-training-in-non-small-cell-lung-cancer-47967https://curecurrent.com/trials/to-evaluate-the-efficacy-of-qlh11811-in-advanced-nsclc-patients-with-egfr-mutation-47968https://curecurrent.com/trials/azd9291-an-irreversible-egfr-tki-in-relapsed-egfr-mutated-non-small-cell-lung-cancer-patients-previously-treated-with-an-47969https://curecurrent.com/trials/efficacy-study-of-osimertinib-in-treatment-na-ve-patients-with-egfr-mutant-nsclc-according-to-tp53-mutational-status-47970https://curecurrent.com/trials/cadonilimab-monotherapy-as-neoadjuvant-therapy-for-resectable-ii-iiia-squamous-cell-lung-cancer-47971https://curecurrent.com/trials/miles-3-cisplatin-in-combination-with-gemcitabine-for-elderly-patients-with-lung-cancer-47972https://curecurrent.com/trials/otl38-injection-for-intraoperative-imaging-of-folate-receptor-positive-lung-nodules-47973https://curecurrent.com/trials/cryoablation-of-intercostal-nerves-for-post-operative-pain-management-in-opioid-tolerant-patients-47974https://curecurrent.com/trials/icis-neoadjuvant-therapy-in-resectable-non-small-cell-lung-cancer-47975https://curecurrent.com/trials/study-comparing-bevacizumab-erlotinib-vs-erlotinib-alone-as-first-line-treatment-of-patients-with-egfr-mutated-advanced-47976https://curecurrent.com/trials/chemo-immunotherapy-induction-followed-by-hypo-radiotherapy-in-la-nsclc-chic-47977https://curecurrent.com/trials/stad-1-small-cell-lung-cancer-toxicity-adjusted-dosing-study-47978https://curecurrent.com/trials/a-study-comparing-immunotherapy-with-chemotherapy-in-the-treatment-of-elderly-patients-with-advanced-nsclc-miles-5-47979https://curecurrent.com/trials/pet-ct-scan-as-a-tool-to-rationalize-the-treatment-of-of-advanced-nsclc-patients-undergoing-first-chemotherapy-47980https://curecurrent.com/trials/miles-4-study-comparing-gemcitabine-and-pemetrexed-with-or-without-cisplatin-in-patients-with-nonsquamous-lung-cancer-47981https://curecurrent.com/trials/elucidate-enabling-lung-cancer-identification-using-folate-receptor-targeting-47982https://curecurrent.com/trials/moderate-hypofractionated-radiotherapy-for-lung-cancer-47983https://curecurrent.com/trials/a-study-on-the-immune-response-to-covid-19-vaccination-in-cancer-patients-the-iosi-covid-19-001-study-47984https://curecurrent.com/trials/pembrolizumab-plus-pemetrexed-for-elderly-patients-with-non-sq-nsclc-with-pd-l1-50-cjlsg1901-47985https://curecurrent.com/trials/a-retrospective-cohort-study-for-main-postoperative-complications-after-sars-cov-2-infection-47986https://curecurrent.com/trials/effects-of-intravenous-gc4419-on-the-incidence-and-severity-of-esophagitis-due-to-chemoradiotherapy-for-lung-cancer-47987https://curecurrent.com/trials/study-of-rofecoxib-and-prolonged-constant-infusion-of-gemcitabine-in-the-polychemotherapy-treatment-of-advanced-nsclc-47988https://curecurrent.com/trials/mp0250-darpin-protein-plus-osimertinib-in-patients-with-egfr-mutated-nsclc-47989https://curecurrent.com/trials/study-of-polymeric-micellar-paclitaxel-platinum-combined-with-sindilizumab-injection-for-advanced-non-squamous-nsclc-47990https://curecurrent.com/trials/pd-l1-expression-in-lung-cancer-47991https://curecurrent.com/trials/donation-of-post-mortem-tumor-tissues-47992https://curecurrent.com/trials/piloting-the-feasibility-of-flt-pet-ct-non-small-cell-lung-cancer-managed-with-sbrt-47993https://curecurrent.com/trials/selumetinib-and-paclitaxel-as-second-line-treatment-in-treating-patients-with-stage-iiib-iv-non-small-cell-lung-cancer-47994https://curecurrent.com/trials/examination-of-trends-in-non-small-cell-lung-cancer-patients-medical-study-experiences-47995https://curecurrent.com/trials/safety-and-efficacy-of-aumolertinib-combined-with-anlotinib-as-1st-line-treatment-in-advanced-lung-cancer-egfr-mutation-47996https://curecurrent.com/trials/the-role-of-ctdna-testing-plus-ai-based-pathology-in-resectable-lscc-47997https://curecurrent.com/trials/first-in-human-study-of-bay2287411-injection-a-thorium-227-labeled-antibody-chelator-conjugate-in-patients-with-tumors-k-47998https://curecurrent.com/trials/a-study-to-evaluate-yh001-in-combination-with-toripalimab-in-subjects-with-advanced-nsclc-and-hcc-47999https://curecurrent.com/trials/upfront-resection-of-locally-advanced-nsclc-followed-by-chemoradiotherapy-48000